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Abstract 
Pulmonary hypertension patients could greatly benefit from use of an implantable 
blood flow and pressure monitor that can be used to derive pulmonary resistance. 
This thesis concentrates on the development of a suitable implantable sensor for 
measuring flow. Various methods for measuring flow are assessed. Conductance 
catheter techniques are proposed as some of the most promising, but suffer from 
limited accuracy. The main chapters of the thesis concentrate on the development of 
more accurate conductance catheter techniques. Realistic three-dimensional dynamic 
models of the heart, developed from MRI and tagged MRI scans, were used with 
finite element analysis to simulate the electric field arising from the conductance 
catheter in the heart. Results show that catheter movement and tissue impedance 
changes give non-negligible error using existing methods for calculating volume 
from impedance measurements. A new method for calculating volume from 
impedance measurements was developed that corrects for these and other errors. The 
new method finds the inverse mapping of a parameterised numerical model. It also 
allows use of additional data available from the conductance catheter technique, 
including data from different current source configurations and frequencies. The new 
technique was tested in a simplified model of the heart. Derivatives of the catheter 
measurements with respect to the model parameters were determined at one 
parameter configuration and formed into vectors. Derivative angles were then found 
between the vectors, providing a method for assessing the separability of the 
different model parameters. In addition they did not require creation of the inverse 
mapping. Two different types of techniques for creating the inverse mapping were 
tested. These were a new technique based on a distance metric and optimisation, and 
traditional artificial intelligence techniques. Even in the presence of no measurement 
error, limitations of traditional artificial intelligence techniques prevented successful 
application. The new technique performed to the order of accuracy of the numerical 
model on the same amount of data the traditional artificial intelligence techniques 
were trained on. The new technique was further developed to compensate for 
measurement error, and resulted in a further increase in accuracy. This thesis has 
developed and tested new conductance catheter methods, and has moved us a step 
closer to enabling practical development of an implantable blood flow and pressure 
monitor. 
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Chapter 1. Introduction 
Background 
Development of implantable blood flow and pressure monitoring technology 
promises to provide improved health information with minimum inconvenience to 
patients as they go about their lives. The developed technology may also transfer to 
non-implantable monitoring. A potential application where the invasive nature of an 
implantable device out weighs potential risks is the pulmonary hypertension patient. 
Such patients have a short life expectancy and current treatment methods are only in 
an early stage of development. 
The condition of pulmonary hypertension is the medical condition where there is 
unusually high blood pressure in the lungs and supplying artery (the pulmonary 
artery). This condition often leads to secondary conditions such as right heart failure 
and consequently has a very high mortality. Mechanisms involved include narrowing 
of the small blood vessels in the lungs, with obstruction of blood flow and the raising 
of pressures. 
Current treatment is either with very expensive drugs or by heart and lung 
transplantation. Treatment drugs act to reduce the increase in vascular resistance in 
the small vessels in the lungs. Vascular resistance may be calculated by dividing 
vascular pressure drop by the vascular flow rate. Assuming a "normal" left atrial 
pressure, vascular resistance can be estimated knowing (mean) pulmonary artery 
pressure and flow rate (left atrial pressure is typically approximated as the capillary 
wedge pressure or end-diastole pulmonary artery pressure). 
Pulmonary hypertension (primary) has only very recently started to draw attention 
from clinicians. This has been due to the recent introduction of pharmaceuticals to 
treat the condition. These pharmaceuticals however only treat the symptoms of the 
condition and not the cause. They delay death and provide a pre-death higher quality 
of life for those with the condition. Effects of the drugs are typically monitored with 
the six minute walk test (how far can a patient walk in six minutes). A more accurate 
assessment of pulmonary resistance would be beneficial in optimising selection and 
dosage. This would reduce costs and improve patient treatment. Improved ability to 
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measure the effect of drugs would allow more efficient drug development and better 
clinical trials (improved study end points). 
Implantable technology is relatively mature. Catheters attached to implantable 
monitoring and control units have been extensively implanted. Pacemakers and 
implantable defibrillators have been the largest application of implantable 
technology. Implantable blood pressure (absolute pressure corrected by external 
atmospheric pressure measuring device) monitoring devices have recently become 
commercially available. They have been demonstrated to be reliable in long term 
trials. However, no implantable blood flow sensor has been developed for routine 
use. The difficulty is accurate continuous measurement of flow. Current high 
accuracy techniques are all intermittent and costly. Alternative techniques with the 
potential for continuous high-accuracy flow measurement currently suffer from 
impediments that limit their accuracy and practicality. The focus of this thesis is on 
developing blood flow sensing methods that have the potential to be used in an 
implanted device in a patient. This is ambitious, since even an equivalent non-
implantable device has never been developed. The aim of the thesis is to move closer 
to achieving this goal. 
The approach this thesis takes is to make an objective detailed assessment of the 
merits of different techniques for measuring blood flow. The thesis then concentrates 
on overcoming methodological limitations related to one of the more promising 
techniques, the conductance catheter. This approach is based on a broad foundation 
of previous research. 
Aims 
Specific aims of this thesis are to: 
1. Identify the most promising techniques for an implantable blood flow sensor. 
2. Develop a numerical model to simulate a conductance catheter. 
3. Use this numerical model to determine the theoretical significance of error in 
existing conductance catheter methods due to the main variables (catheter 
position and tissue impedance). 
4. Develop a method to correct for these main variables and other errors. 
5. Further develop the new method by reducing the effect of noise. 
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Structure 
The thesis is composed of seven chapters. These seven chapters comprise an 
introduction, background, literature review, three investigation chapters and a 
conclusion. The investigation chapters are structured with individual methods, results 
and discussion sections. There is limited interpretation of the data in the results 
section and the results and discussion sections should be read together to fully 
interpret the results. 
The second chapter presents background information. Included is basic relevant 
anatomy and physiology of the heart related to aim two, and a detailed introduction 
to the conductance catheter technique, for the unfamiliar reader. 
The third chapter presents a detailed literature review. It concentrates on addressing 
the first aim of the thesis and relevant research data related to aim two. 
The fourth, fifth and sixth chapters are the investigation chapters. These main 
chapters of the thesis concentrate on the development of the conductance catheter 
technique. These chapters address aim three, four and five of the thesis respectively. 
In chapter four, dynamic three-dimensional numerical models of the heart are 
developed to enable simulation of the conductance catheter. Two different models 
are used: one developed from MRI and one developed from tagged MRI data. The 
two models allow comparison of models developed from two different patients. One 
of the models (tagged MRI) is then used to assess the effect of catheter position and 
blood conductivity/myocardium conductivity on the conductance catheter output. No 
one has previously undertaken such detailed studies in the controlled environment of 
a realistic, three-dimensional numerical model. The outcome of these studies provide 
the motivation for the work in the next two investigation chapters. 
In chapter five a new methodology for mapping conductance catheter voltages to 
blood flow (stroke volume) is developed. The approach involves developing an 
inverse solution to the numerical model. Two different inverse methods are applied 
and compared, a new technique based on a distance metric and optimisation, and the 
neural network (direct arbitrary function fitting) technique used commonly with 
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inverse problems. This chapter only assesses the performance of inverse mapping 
with no error. The outcome of this chapter provides motivation for the last 
investigation chapter. 
In chapter six the new inverse technique is further developed based on probability 
concepts and applied to the inverse problem with error. 
The conclusion brings the literature review and three investigation chapters together 
and provides direction for possible future work. 
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Chapter 2. Background 
2.1 Introduction 
This chapter presents material related to the second aim of the thesis and a detailed 
introduction to the conductance catheter technique for the unfamiliar reader. The first 
section covers basic heart anatomy and physiology. The second section, introduces 
the conductance catheter technique. Numerous raw figures carefully selected from 
books and research literature are included in this chapter. Diagrammatic explanations 
have been included from other sources to more efficiently communicate the 
discussions for the reader. These have been referenced as required by copyright law 
(review and criticism purpose). 
2.2 Basic Heart Anatomy and Physiology 
As indicated in Figure 2.2.1 the heart of a normal person contains two pumps in 
series. The right pump delivers blood to the lungs and receives blood from the body. 
The left pump delivers blood to the body and receives blood from the lungs. One 
way valves control the flow of blood into and out of the heart (not shown). The heart 
' 
muscles contract to eject blood through the one way flow path created by the valves. 
The heart consists of four cavities. Blood flows into a receiving chamber, the right 
atrium, before flowing through a valve, the tricuspid valve, into the main pumping 
chamber, the right ventricle. From here the blood flows through another valve, the 
pulmonary valve, into the pulmonary trunk, which branches into two vessels, the 
right and left pulmonary arteries, which supply the right and left lungs respectively. 
Blood flows from the lungs through four vessels. These four vessels are the 
pulmonary veins. From these pulmonary veins the blood flows into a receiving 
chamber, the left atrium, then through a valve, the mitral valve, into the main 
pumping chamber, the left ventricle. From the left ventricle blood is ejected through 
another valve, the aortic valve, into a vessel, the aorta, which supplies blood to the 
body. 
5 
5 
Right 
lung.....,_~ 
6 
Capillaries l l 
~Lower 
body 
Pulmonary 
trunk 
Left 
pulmonary artery 
5 Left lung 
6 
Descending aorta 
Fig. C-1 Blood flow through the heart and peripheral circulatory system. 
AA, Aortic arch; IVG, inferior vena cava; LA, left atrium; LV, left ventricle; RA, 
nght atrium; RV, nght ventricle; SVC, superior vena cava. 
Figure 2.2. l: Schematic of blood flow path through the four chambers of the heart. 
[79]. 
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Figure 2.2.2 shows the detailed blood flow from the heart through the body. 
Essentially the volume of blood that flows through the right side of the heart must be 
the same as the volume of blood that flows through the left side of the heart. A small 
amount of blood does actually bypass the right heart through the bronchial arteries, 
but this is very small (less than 1 %) and practically negligible. The coronary arteries 
supply blood to the heart itself. One way valves in the veins of the extremities help to 
pump blood back to the heart against gravity. All blood vessels are non-rigid and 
distensible to some extent. However, the veins, carrying blood from tissues of the 
body back to the heart are considerably more distensible than the arteries which carry 
blood to the tissues. 
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Figure 1-4 • Schematic diagram of the parallel and series arrangement of the vessels composing the 
circulatory system. The capillary beds are represented by thin lines connecting the arteries (on the 
right) with the veins (on the left). The crescent-shaped thickenings proximal to the capillary beds 
represent the arterioles (resistance vessels). (Redrawn from Green HD: ln Glasser 0 , editor: Medical physics, 
vol 1, Chicago, 1944, Mosby- Year Book.) 
Figure 2.2.2: Simplified schematic of the circulatory system - flow of blood from the 
heart around the body. [80]. 
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Figure 2.2.3 shows the location of the heart in the body. The heart is located in the 
pericardium, a double membrane, fluid filled sac. This fluid filled sack is only 
slightly distensible and has limited ability to stretch limiting the volume of the heart 
in the short term. The inner membrane of the pericardia! sac lies on the outer heart 
surface (epicardium) and the thicker outer membrane is the fibrous pericardium. On 
either side of the heart are the lungs contained in their own fluid filled sac. Below the 
lungs and heart is the diaphragm and below this, directly underneath the heart, is the 
liver (not shown). Adipose tissue or fat may lie around the various organs. 
Superior Jobe of right lung 
HO'izon1al fissure 
Millie lobe of right lung 
Oblique fissure 
klferior lobe of right IUng 
Coslodiaphragmatlc recess 
Figure 2.2.3: Heart located in the pericardium. [81]. 
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Superior lobe of lelt lung 
Fibrous pericardium 
Visceral layer of serous pericardium 
Mediastinal surface of lung 
Oblique fissure 
Inferior lobe of lelt lung 
The pericardia! membrane inverts at the veins and arteries entering and exiting the 
heart as shown in Figure 2.2.4. 
Superior vena cava Ugamentum arteriosum 
Posterior wall of obliQue pericardia! sinus 
Parietal layer of serous pericardium 
Inferior vena cava 
B. Anlarior View 
Figure 2.2.4: Pericardium membrane with heart removed. [81]. 
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The lungs do not completely surround the heart as can be seen in body cross section 
of Figure 2.2.5. The pericardium is attached rigidly to the sternum at the front by 
way of the sternopericardial ligaments (not shown). One of these ligaments is near 
the base of the pericardium, the other is higher up. Higher up still, the thymus (not 
shown) lies between the pericardium and sternum. The thymus is only significant in 
size during childhood. In humans the base of the pericardium is bonded to the 
diaphragm. 
Sternal reflection of left pleura 
Costomedlastinal recess 
Fatpad 
Lett phrenic nerve 
CUal1endon 
ollia!ffagm 
A. SUperior View Sympathetic trunk 
Figure 2.2.5: Cross section of the body at the base of the pericardium. [81]. 
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Central tendon 
of diaphragm 
Figure 2.2.6 shows the location of the heart underneath the sternum and ribs/costal 
cartilages. 
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S"P·+ lol 
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+-
Long axis 
of body 
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Base of 
ventricular mass 
Figure 2.2.6: Position of the heart relative to external body markings. [82]. 
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Figure 2.2.7 shows an anterior (front) view of the heart removed from the 
pericardium. The cut away shows the right ventricle, pulmonary valve and tricuspid 
valve. Also shown is the outside of the right atrium towards the top left of the image 
and the end of the left atrium wrapping around the heart on the top right of the 
image. 
Pulmonary trunk 
superior vena cava~ Conus arteliosus (infundibulum) 
SUpraventricular crest 
lnterventricular septum 
Anterior cusp 
Posterior papillary muscle 
Posterior cusp of tricuspid valve 
Anterior papillary muscle 
A. Anterior View 
B 
Figure 2.2.7: A.) Anterior view of the heart removed from the pericardium with 
cutaway of the right ventricle. B.) Blood flow through the right side of the heart. 
[81]. 
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Figure 2.2.8 shows a surgical view of the heart in the pericardium after removal of 
the sternum and opening of pericardium. The image is rotated 90 degrees 
anticlockwise to that in Figure 2.2.7. In contrast to Figure 2.2.7, this heart shows 
unusually little epicardial fat. 
Figure 2.2.8: Surgical view of the heart in the pericardium with the sternum removed 
and pericardium opened. [82]. 
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Figure 2.2.9 shows a posterior (back) view of the heart removed from the 
pericardium. This figure shows the matching cut surfaces of the heart in Figure 2.2.4. 
The outer surface of the left ventricle is shown on the bottom left of the image. Entry 
of the four pulmonary veins to the left atria is shown along with entry of the superior 
vena cava and inferior vena cava to the right atrium. The aorta from the left ventricle 
passes around the pulmonary trunk from the right ventricle. 
Left 
pulmonary 
veins 
Coronary 
Pulmonary 
lrunk 
groove -----,7,J:..,--....,...:.+---''c---;""' 
Left 
ventricle 
Right ventricle 
Ascending Transverse sinus 
aorta of pericardium 
Cardiac 
crux 
/ 
=--- Superior 
vena 
cava 
Right 
- pulmonary 
veins 
Oblique sinus 
of pericardium 
Right atrium 
Left atrium 
Posterior 
interalrial 
groove 
Inferior vena cava 
Fig. 60.2 The base and the diaphragmatic surface of the heart. The serosal 
pericard ium is in situ and its cut edge is seen around t he great vessels; its 
disposition is highly schematic (recesses omit ted). See text for add itional deta ils. 
The cardiac crux results from the confluence of the posterior interatr ial groove, 
the posterior atrioventricular groove and the posterior interventr icular groove. 
Figure 2.2.9: Posterior view of the heart removed from the pericardium. [83] 
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The apex, base of the ventricles and the long axis of the heart are indicated in Figure 
2.2.6. Figure 2.1 .10 shows slices of a real heart perpendicular to the long axis of the 
heart from apex (bottom) to base of ventricles (top). The circumference of the 
circular shaped hole is the left ventricle endocardium. The circumference of the 
crescent shaped hole is the right ventricular endocardiurn. The white tissue is adipose 
tissue or fat. The darker tissue is heart muscle (myocardium). 
Figure 2.2.10: Short axis slices of the ventricles from apex bottom to base. [84] 
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Figure 2.2.11 shows a heart cut along the long axis of the heart to reveal the four 
chambers. ote the thicker wall of the left ventricle to the right ventricle, the thin 
walls of the atrium, and trabecularised (uneven) endocardium of the right ventricle 
and to a lesser extent trabecularised endocardium of the left ventricle. 
Figure 2.2.11: Long axis cut of the heart revealing the four chambers. [84] 
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Figure 2.2.12 shows a heart cut through the left ventricle and left atrium along the 
long axis of the heart approximately perpendicular to Figure 2.2.11. 
Figure 2.2.12: Long axis cut of the heart through the left atrium and ventricle. [82]. 
Figure 2.2.13 shows a dissection of the heart valve plane (perpendicular to the long 
axis of the heart). The valve plane separates the atria, aorta and pulmonary trunk 
from the ventricles. Note the aortic and pulmonary valves have three bucket leaflets, 
the mitral valve has two flat leaflets supported by cords and the tricuspid valve has 
three flat leaflets supported by cords. 
17 
Figure 2.2.13: Dissection of the heart valve plane. [82]. 
Figure 2.2.14 shows a surgical view of the thin tricuspid valve from the right atrium 
side. 
Figure 2.2.14: Surgical view of the tricuspid valve from the right atrium. [82]. 
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A typical human heart measures 12-13cm from top to bottom, 7-8cm at its widest 
point and weighs 325 grams. The volumes of the four cardiac chambers are 
approximately: LA= 45ml, RA= 63ml, LV = lOOml, RV= 130ml. Typical length 
of the cardiac cycle is 750ms with 270ms systole (emptying of the ventricles) and 
480ms diastole (filling the ventricles). Performance of the heart is given by the 
indices: heart rate in beats per minute (HR), stroke volume (SV), end diastolic 
volume (EDV), end systolic volume (ESV), ejection fraction and cardiac output 
(CO), where: SV = EDV - ESV and CO = HR x SV (assuming no valve leakage). 
EDV and ESV are different for each ventricle. Typical stroke volume is 70ml. 
Typical cardiac output is 5 1/min. Cardiac output increases during stress and exercise. 
Maximum heart rate is commonly estimated as (240 - age) bpm. EDV and EDS can 
increase and decrease respectively by about 50% to around 200ml and to around or 
less than 30-35ml respectively [85]. Respiration and posture have an effect on SV, 
CO, and HR. CO is 20% lower when standing than when lying down. HR is 5-10 
beats per minute faster in erect than in supine and 10-28% greater when standing. CO 
also decreases with age [86]. Right ventricle stroke volume increases with inspiration 
(cyclic respiratory change = 20% p-p typical) while left ventricle stroke volume 
decreases (cyclic respiratory change = 20% p-p typical) and heart rate increases. The 
opposite changes occur with positive pressure ventilation. 
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2.3 Conductance catheter 
The conductance catheter technique has been used to measure left and right 
ventricular volume. The technique has been applied in humans, sheep, dogs, pigs, 
rabbits and rats. The technique has also been used to determine atria volume and 
blood vessel volume (cross-sectional area). The technique exploits the contrast in 
electrical impedance between the blood and surrounding tissue. 
The most commonly used technique uses an eight electrode catheter (with pigtail 
typically) placed in the left ventricle from the aorta as shown in Figure 2.3.1. Current 
is injected between an electrode near the apex and an electrode just outside the aortic 
valve. Electric potential differences are measured across n - 1 segments between the 
n intermediate electrodes, where n is typically 6 but commonly varies between 3 and 
6. Use of separate measurement and source electrodes eliminates artifacts due to 
polarisation and the effect of the local electric field of the source electrodes. 
FIG I Schematic representation of eight-electrode 
catheter placed along the long axis of the left ventricle. 
Dashed lines indicate equipotential surfaces defining blood 
segments. 
Figure 2.3 .1: Conductance catheter in the left ventricle. [87]. 
Ventricle volume, V, is determined using the formula, 
v(t)=(! )( 1:, )a(t)-c,), 
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(2.3.1) 
where: G(t) = It__!__ , crb = blood conductivity, L = electrode spacing, E1 = measured 
•=1 E, 
potential difference segment i, I= injected current, a= gain factor, Gp = parallel 
conductance. 
The stroke volume is simply determined from the difference between end-diastolic 
and end-systolic volume. 
Blood conductivity is most commonly determined using an external temperature 
regulated conductance cell with withdrawn blood. Calibrated impedance 
measurement using closely spaced electrodes on a customised catheter has also been 
used. Closely spaced electrodes reduce the effect of surrounding tissue on blood 
measurements. 
Parallel conductance is sometimes not measured and is assumed zero. Using (2.3.1) 
parallel conductance cancels out when calculating stroke volume. The term accounts 
for current flow through tissue surrounding the blood volume being measured. The 
most commonly used method for determining parallel conductance involves an 
injection of saline. A small bolus of hypertonic saline is injected through a balloon 
floatation catheter in the pulmonary artery. The highly conductive saline transiently 
changes the conductivity of blood, practically without affecting parallel conductance. 
A plot of end diastolic G against end systolic G is made as the bolus passes through 
the left ventricle. The intersection of the line of best fit with the line: end diastolic G 
= end systolic G, gives the parallel conductance. This point represents the condition 
when the blood conductivity is zero and all current flows through the parallel 
conductance. Different frequencies give a different contrast between blood and tissue 
impedance, and this has also been used to determine a value for parallel conductance, 
however this approach is usually calibrated using the saline technique, and only 
accounts for dynamic changes in parallel conductance. 
The gain factor in (2.3 .1) is assumed one or is calculated by comparing the stroke 
volume predicted by (2.3.1) with another technique of stroke volume measurement 
such as angiography or thermodilution. 
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Typically an excitation current of around 30µA at 1-1 OOkHz is used for 
measurements. This current is well below the value required to activate cardiac 
muscle. Continuous sinusoidal current is used and measurement voltages are filtered 
to remove cardiac (low frequency) and muscle activation artifacts. Conductance 
catheter systems are commercially available from a number of sources (e.g. CD 
Leycorn/CardioDynamics BV, Inc. , Zoetermeer, The Netherlands, and Millar 
Instruments, Inc. , Houston, USA). 
A dual field excitation configuration has been used to improve current density 
uniformity in the left ventricle [88]. The dual field excitation configuration uses an 
additional current source of opposite polarity and smaller magnitude placed outside 
each current source. This approach uses the same formula with the current as the sum 
of the two currents and a catheter with two more electrodes as shown in Figure 2.3.2. 
Typically four electrode miniature catheters, with only one segment are used in rats . 
. 
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Fig. l. Schematic representation of a conductance catheter positioned 
along long axis of left ventricle (LV). Conventional single-excitation 
field is generated by passing a current I, via electrodes 1 and JO. Super-
position of a 2nd current le via electrodes 2 and 9 results in a "dual-
excitation" field. Ratio of the 2 currents isf = 0.3. Dotted lines represent 
division of ventricle into 5 segments. Voltage over each segment is 
measured continuously and divided into total current to yield segmental 
conductances. Note that 1-10 and 2-9 currents are opposite in polarity. 
Figure 2.3.2: Dual excitation conductance catheter in the left ventricle. [88]. 
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Chapter 3. Literature Review 
3.1 Introduction 
The aim of this chapter is to assess different blood flow techniques for implantable 
use in humans (aim one of the thesis) and provide research data relevant to 
simulation of the conductance catheter (aim two of the thesis). The chapter will start 
by assessing a wide range of blood flow measurement techniques. Previous research 
in the area of conductance catheters will then be discussed (related to identifying 
major variables for aim 3 of the thesis and previous work in the area of aim four). 
Finally, topics important to the simulation of a conductance catheter will be 
discussed. Electrical properties of blood and tissue will be discussed followed by a 
discussion of heart anatomy and physiology research relevant to the thesis. 
Numerous raw figures and tables carefully selected from research literature are 
included in this chapter. Diagrammatic explanations have been included from other 
sources to more efficiently communicate the discussions for the reader. Raw tables 
have been included to eliminate any possibility of error or misinterpretation in 
reproduction. These have been referenced as required by copyright law (review and 
criticism purpose). Sufficient detail needed for good decisions is carefully included 
in the raw data for the curious reader, but the discussion is minimised to avoid over 
elaboration of detail. 
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3.2 Implantable Blood Flow Measurement Techniques for Humans 
This section reviews current techniques for measuring blood flow in regard to 
measuring cardiac output with an implanted device. While blood flow is routinely 
obtained both in humans and animals using invasive nonimplantable sensors, the 
challenge is to develop reliable methods for implantable blood flow sensing in 
humans. Existing techniques, while effective in hospital or animal research settings, 
are generally undesirably invasive, making them unsuitable for use in humans. 
Cardiac output (blood flow rate) was first measured in animals in the 1890's using a 
variety of indicator techniques. Cardiac output monitoring in humans originated in 
the 1940's with the advent of catheterisation. Flow measurements were obtained in 
animals in the 1960's using an implanted Doppler ultrasound device that transmitted 
flow signals to a nearby receiver [1]. Recently human implantable monitors, similar 
to pacemakers, have been developed that incorporate a mixed venous oxygen sensor 
[2]. These sensors are of limited use for blood flow monitoring since blood flow is 
also dependent on artery oxygen saturation and oxygen consumption. 
Although a practical implantable blood flow sensor has not been developed, the 
technology for long term implantable monitors incorporating sensors on an attached 
catheter through the heart, is mature. Heart pacing devices are used routinely in 
humans. Implantable devices, similar to pacemakers, have been developed to 
continuously measure pulmonary artery and right ventricular pressures in humans. 
Catheter stabilization in the pulmonary artery was found to be a problem [3] and 
more recent devices [ 4] use a sensor fixed in the right ventricle to estimate 
pulmonary pressures. These devices are commercially available: Chronicle®, 
Medtronic, Inc., Minneapolis, USA. These devices use a titanium diaphragm and a 
polyurethane window to measure pressure [92]. 
Here we consider the specific advantages and disadvantages of various blood flow 
measurement techniques, including indicator methods and techniques to measure 
velocity and stroke volume. The intracardiac impedance method is considered in 
particular. 
24 
Blood Flow Measurement Techniques: Indicator Methods 
Absolute flow has been determined from the change in concentration of an indicator 
in blood from either a steady state or transient injection of a measured quantity of 
indicator. These methods include Fick's method. 
For steady state injection of indicator, 
Q = dm/ dt b.C , (3.2.1) 
where: Q = flow, m = mass of indicator added, t = time, b.C = concentration of 
indicator downstream of injection point - concentration of indicator upstream of 
injection point. 
Fick observed in 1870 that (3.2.1) could be applied to oxygen transfer across the 
lungs. The method was not practical in humans until the 1940's, after the advent of 
cardiac catheterisation. Arterio-venous difference in oxygen concentration is 
obtained using central venous and arterial catheters. Venous oxygen concentration 
varies considerably. Central venous access provides a mixed estimate of venous 
oxygen concentration. Oxygen consumption is obtained by breathing through a flow-
meter with oxygen sensor. Oxygen sensors have poor accuracy with high levels of 
inspired oxygen limiting the applicability of the method to certain patients [ 5]. 
Techniques using carbon dioxide transfer across the lungs instead of oxygen have 
been developed that do not require cardiac catheters. Recently, intermittent partial 
rebreathing has been used with a differential form of (3.2.1) to obtain semi-
continuous cardiac output [ 5]. The technique still requires the patient to be under 
mechanical ventilation. 
For transient injection of an indicator, 
Q= m f C(t)dt ' (3.2.2) 
where: Q = flow, m = mass of indicator added, t = time, C(t) = concentration of 
indicator downstream of injection point - steady state concentration of indicator 
before injection. Methods employing (3.2.2) typically eliminate recirculation from 
the measured C(t) using curve extrapolation before calculation. 
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The thermodilution technique, introduced in the 1970's, uses heat as the indicator in 
(3.2.2). Typically a small bolus of cold saline of known quantity and temperature is 
injected into the right atrium using a catheter. The cold saline mixes with the blood 
in the right ventricle. The temperature of the blood in the pulmonary artery is then 
measured using a thermistor mounted on a catheter. The technique can only be used 
intermittently due to the fluid loading it causes. More recently, semi-continuous 
thermodilution techniques have been developed where the blood is heated slightly 
with a heater rather than cooled with a bolus, preventing fluid overload [6]. These 
semi-continuous techniques typically suffer from lower signal to noise ratio. 
Recently, a Lithium dilution technique has been developed that requires only a 
central venous catheter rather than the more invasive pulmonary artery catheter used 
in thermodilution [7]. Other indicators [8] that have been used in conjunction with 
(3.3.2) include dye (typically Indocyanine Green), saline with a different 
conductivity than blood, and radioactive substances. 
Blood Flow Measurement Techniques: Velocity Measurement Techniques 
Blood velocity has been measured with electromagnetic sensors, transit time 
ultrasound, Doppler ultrasound and laser Doppler systems. Less successful 
techniques include thermal transport (heat loss induced by flow), pressure gradient 
[9] and a bristle type meter (drag force induced by flow) [8]. 
Electromagnetic flow meters and transit time flow meters are commonly used in 
animal experiments. The sensors are incorporated into a unit that fits over a blood 
vessel. Due to the invasiveness of fitting the units over blood vessels, they are not 
used in humans. 
Electromagnetic flow meters have been devised that setup a magnetic field 
perpendicular to the direction of blood flow in various ways [9]. As ions in the blood 
pass through this magnetic field they are acted upon by a force perpendicular to both 
the flow direction and the applied magnetic field. Electrodes measure the balancing 
electric potential. Mean flow velocity, V, is given by, 
V=~ 
Bd' 
26 
(3.2.3) 
where: E = measured potential between electrodes, d = electrode spacing, B 
magnetic flux density. 
Electromagnetic flow-meter techniques have overcome unstable voltages from 
electrode polarization and ECG interference by using a square or trapezoidal time-
varying magnetic field. Induced EMF problems are associated with AC excitation. 
Coils used to create the field typically consume considerable power. In addition to 
external vessel units, catheter based electromagnetic flow-meters have been devised, 
but are highly sensitive to position. 
Transit time flow-meters, using the difference between travel times of upstream and 
downstream ultrasonic waves transmitted between small piezoelectric transducers, 
have been constructed in various configurations [9]. Gel is used to ensure good 
signal conduction between external probes and tissue. Catheter mounted transit time 
devices have been constructed [91] but are highly sensitive to position. The mean 
flow velocity, V, is given by, 
V = c2!!,.T 
2d cosB 
(3.2.4) 
where: !!,.T = difference between upstream and downstream travel times, c = speed of 
sound, d = travel distance of signal, e = angle between flow direction and signal 
travel. 
Phase detection rather than pulse timing, between upstream and downstream 
waveforms, is typically used to determine the typically extremely small time 
difference (of the order of 1 ns). 
Pulsed Doppler systems, using frequency shifts in ultrasound signals scattered from 
red blood cells [10], offer the benefit of isolating velocity at different depths. 
Velocity, V, is given by, 
cM' V=---
2FcosB 
(3.2.5) 
where: M' = frequency shift, c = speed of sound, F = signal frequency, e = angle 
between flow direction and signal travel. 
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Continuous wave Doppler systems provide more extensive frequency information 
but cannot recover depth information. Modem ultrasound transducers use an array of 
piezoelectric crystals. Beam steering, by inserting time delay offsets between crystals 
in arrays, allows three-dimensional information to be recovered from a static probe. 
Handheld probes incorporating transducers are commonly used to measure blood 
flow in the ascending aorta. The probes are interfaced to the skin with gel to ensure 
good signal conduction. Recently, oesophageal Doppler, where a flexible probe is 
inserted orally into the oesophagus of an anaesthetized, mechanically ventilated 
patient, has been used to measure flow in the descending aorta [5]. More recently, 
intracardiac catheter mounted arrays have been used in the heart to aid heart surgery 
[11]. Doppler measurement is highly sensitive to probe positioning and signal 
processing can consume large amounts of power (especially for array transducers). 
Vessel wall motion artifacts can usually be removed successfully with a high pass 
filter. 
Laser Doppler, using the frequency distribution of scattered light waves from red 
blood cells in flowing blood [12], is limited by laser penetration, on the order of only 
1 mm, into blood and tissue. Laser Doppler has been used to determine blood 
perfusion in the microcirculation of tissues. 
Blood Flow Measurement Techniques: Stroke Volume Measurement 
Techniques 
Stroke volume methods are based on the difference between end-diastolic and end-
systolic volume of a heart ventricle. Accuracy of these methods may be degraded if 
heart valve operation is abnormal. The left ventricle has a relatively simple geometry 
and methods have been developed, by using geometrical assumptions, to determine 
its volume relatively well from little dimensional information. However the right 
ventricle geometry is much more complex, and more data is needed to obtain its 
volume with the same accuracy. Various imaging techniques such as angiography, 
magnetic resonance imaging, CT and echocardiology have been used to obtain 
dimensional information for the determination of ventricular volume. However all 
these techniques are time consuming and manual digitization is needed to extract 
accurate dimensional information from the images. Other techniques used to obtain 
ventricular dimensions include intracardiac impedance, transcardiac conductance, 
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radionuclide ventriculography and sonomicrometry. Radionuclide ventriculography 
has poor accuracy and temporal resolution [ 13]. Sonomicrometry requires small 
ultrasonic piezoelectric transducers to be sewn onto the myocardium which is far too 
invasive for human use. 
Intracardiac impedance has been used to assess the volume of the heart chambers. 
The technique exploits the contrast in impedance of blood and surrounding tissue. 
The technique involves measurements of electric potential from current source(s), 
using electrodes in the heart chambers. 
Reference [14] describes the method most commonly used today for ventricular 
volume measurement using intracardiac impedance. The technique employs an eight 
electrode catheter that injects current (30 µA, 20 kHz) between an electrode near the 
apex and an electrode just outside the aortic valve of the left ventricle. Electric 
potential differences are measured across each segment between the six intermediate 
electrodes. The separation of measurement electrodes from source electrodes 
eliminates artifact due to polarization and the local electric field of source electrodes. 
Ventricular volume, V, is determined from these measurements using, 
V(t)= (~)( ~: )a(t)-G, ), (3.2.6) 
where: G(t) = l°t __!__ , crb = blood conductivity, L = electrode spacmg, E 1 
•=I E, 
measured potential difference, I= injected current, Gp= parallel conductance, a 
gain factor. 
Parallel conductance is typically determined using a small bolus ofhypertonic saline 
injected through a catheter [15]. The gain factor is calculated by comparing the 
stroke volume predicted by (3.2.6) with another technique of stroke volume 
measurement such as angiography or thermodilution. 
A method for in vitro blood resistivity determination has been presented [16]. 
Formulae were provided to calculate blood resistivity from impedance between 
29 
closely spaced electrodes on two custom-made catheters positioned well away from 
heart tissue. 
The intracardiac impedance technique has primarily been used in the left ventricle of 
animals. Current intracardiac impedance methods can give a reasonable relative 
volume measurement under certain conditions, however repeatability is poor and the 
relation to absolute volume is not well defined. The technique has been investigated 
for rate-adaption of pacemakers but it is not currently used [ 109-111]. 
A less invasive transcardiac conductance technique has been developed where 
current is applied between an electrode catheter in the superior vena cava and an 
external electrode. Potentials are measured from additional external electrodes [18]. 
The technique uses the same formula, (3.2.6), as the intracardiac impedance method. 
Blood Flow Measurement Techniques: Other Methods 
Other techniques developed to measure cardiac output include arterial pulse contour 
techniques and bioimpedance. The pulse contour method, using circulation models, 
is sensitive to compliance changes of vessels and needs to be regularly calibrated by 
another flow technique [ 5]. Bioimpedance, using impedance changes between upper 
and lower thorax (different principle from intracardiac impedance), while non-
invasive has been reported to perform poorly [19]. 
Venous occlusion is used for regional flow assessment in humans [9]. Radioactive 
and dye microsphere indicators are used for regional blood flow evaluation in animal 
experiments [20]. Injected microspheres wedge in tissue and blood flow is 
determined from the concentration of microspheres in a volume of extracted tissue. 
Positron emission tomography, using radioactive tracers, is used to assess regional 
blood flow changes in neural science research [21]. 
Techniques for an Implantable Sensor 
An implantable blood flow sensor must have characteristics that include small size, 
an output that is stable and reliable over extended periods (avoiding the need for 
recalibration), operation for extended periods using a small power source (besides 
other limitations, through-skin recharging is inconvenient for patients), avoidance of 
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left-side implantation (due to increased risk of stroke), minimal invasiveness and 
reasonable cost. Of great significance is the severe power limitation of the device, 
given the relatively large power requirements of some blood flow sensing methods. 
Limited power eliminates the potential to use energy demanding, heater 
thermodilution techniques for regular flow. Implantable monitors cannot use 
indicator methods (except possibly for an indicator already in the blood) for 
measuring flow since indicator would have to be stored in the monitors. Velocity 
techniques are sensitive to position and blood flow distribution and these problems 
would have to be overcome for a reliable flow meter. Pulsed Doppler ultrasound 
from an array catheter could potentially be the best velocity technique in this regard, 
however signal processing requires bulky and power consuming electronics. In 
addition, for an array, a thin catheter may have to contain many transmission lines 
resistant to fatigue. The intracardiac impedance method in the right ventricle 
potentially provides very low power, continuous flow monitoring. However 
problems of sensitivity to parameters like blood and tissue impedance and catheter 
movement would have to be overcome. The right heart can significantly dilate in 
conditions such as advanced pulmonary hypertension and the algorithm used in such 
a case would have to be patient dependant. Valvular regurgitation or right heart 
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failure could prevent the technique from providing an accurate flow assessment. 
Conclusion 
There is no single blood flow sensing technique that promises to be superior in every 
aspect for implantable use in humans. While ultrasound techniques hold significant 
potential, impedance electrode techniques may be preferred due to simplicity and 
low power requirements. 
3.3 Conductance Catheter 
The conductance catheter technique is a simple technique and research has not 
progressed much further than the commonly used method [14] discussed in Section 
2.3. Most research literature simply repeats essentially the same experiment and adds 
negligible original work. Hundreds of papers have been published like this and there 
is little benefit in reviewing them all. Several authors have proposed methods to 
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improve the conductance catheter technique besides the use of an extra set of current 
source electrodes [88] to improve current uniformity in the left ventricle as discussed 
in Section 2.3. One author proposed a technique called field extrapolation to achieve 
a similar result [106-107]. Several authors have attempted to determine parallel 
conductance using frequency changes in myocardium conductivity instead of, or in 
conjunction with, the saline dilution method [93-97]. An alternative saline dilution 
method has been proposed, based on the integral of the conductivity change from 
saline injection; similar in concept to thermodilution but based on conservation of 
ions rather than conservation of energy. The method was demonstrated to be more 
accurate than the conventional technique but blood flow rate was needed in the 
calculation [98]. A method has also been proposed to correct for catheter curvature 
for a right ventricular catheter curved between tricuspid valve and pulmonary artery. 
The technique uses electrode spacing that is the projected distance between 
electrodes on the direct path between source electrodes. However the technique 
requires knowledge of the catheter curvature, or some way of calculating it [99]. The 
residual volume between source electrode at the apex of the left ventricle and the 
adjacent measuring electrode has been accounted for by multiplying the conductance 
in the next segment by 4/3 [ 15]. 
The effect of catheter position in the left ventricle has been assessed usmg a 
simplified model of the conductance catheter in the left ventricle. Typical error from 
off-center catheter was rated at 8-20% volume under estimation, with worst case 20-
30% in systole and 35-40% in diastole [100]. Moving a catheter 5mm off-center in 
the left ventricle has been associated with approximately 5% volume under 
estimation [108]. The quality of conductance catheter signals from a wide range of 
catheter positions in the right ventricle has been assessed in animal experiments [ 17]. 
A free-breathing human right ventricular catheter study [101] indicated that "animal 
models where respiration is controlled by artificial ventilation thus give a false 
impression of the stability of data that can be obtained in the conscious human 
subject". The study reported "The effect of respiration on conductance derived 
volumes was variable and unpredictable, and this source of variability was 
minimised by selecting sections of data at held end expiration for all analyses". A 
three dimensional numerical model has been developed from MRI scans to simulate 
the conductance catheter in the ventricles [102]. The results aimed to investigate 
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error in saline dilution measurement of parallel conductance. The approach involved 
removal of surrounding tissue to estimate 'true' parallel conductance. However, true 
parallel conductance and gain are, by definition, essentially the coefficients of a 
linear equation fitting conductance catheter volume to real volume. They would 
therefore be better estimated by performing linear regression on the conductance 
measurements for a change in volume. This would give average coefficients over the 
change in volume. Determining the volume requires the numerical model to include 
the entire ventricle, including ventricle length changes. 
-3.4 Passive Electrical Properties of Blood and Tissue 
In this section the bulk electrical properties of tissue and blood will be reviewed. The 
permeability of blood and tissue is equivalent to air, whereas dielectric properties, 
permittivity and conductivity, vary considerably and in complex ways. An excellent 
history and review of general dielectric properties of blood and tissue has been 
published [22]. Here multiple sources including such review articles will be 
integrated to provide the most appropriate property values for work in this thesis. 
The scope of this section will be limited to what is relevant to this thesis. The 
numerical modelling procedure used in Chapter 4 of this thesis allows specification 
of a single local material axis. Local bulk conductivity and permittivity tensors based 
on this single material axis can be defined. These tensors have the restriction that off-
diagonal terms of the matrix are zero. Thus, in general, we can only model situations 
where the principal axes of these tensors match the local material axes. 
Essentially all tissue except muscle can be approximated as being isotropic. Muscle 
is generally assumed to be isotropic perpendicular to fibre direction but different in 
the fibre direction. Cardiac muscle is often represented as a bidomain and care is 
taken here to present only bulk properties which are relevant for modelling passive 
electrical conduction. 
There are several different terminologies used for stating dielectric properties in the 
literature. The most usual and most natural form is the conductivity and permittivity. 
Alternatively these properties can be stated in terms of complex impedance. 
Sometimes the resistivity, which is the inverse of conductivity, is stated. Some 
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tissues are electrically active, but at the low magnitudes of current and voltage in the 
application in this thesis only passive electrical properties are relevant (below 
stimulation threshold) and will be discussed here. The frequency dependency of 
conductivity and permittivity is governed by several dispersions (changes with 
frequency). At very low frequency around 100 Hz there is a very complex alpha 
dispersion below which permittivity is very high. In the high kilohertz/megahertz 
range, capacitive shorting of thin insulating cell membranes separating electrolyte 
compartments causes beta dispersion. Typically anisotropic properties become 
isotropic above this dispersion. Higher frequency dispersions are typically the result 
of relaxation effects (process limited in speed) at the macromolecule and water 
molecule level. In general, below the beta dispersion, cell death causes conductivity 
to increase (at constant temperature) and any anisotropy to decrease due to 
membrane failure. In general, little is known about the conductivity and variability of 
conductivity of living tissue, especially myocardium. 
Electrical conductivity of blood and heart (myocardium) will be treated first followed 
by general tissue conductivity and permittivity. Detailed heart tissue fibre orientation 
will be discussed in Section 3.5. 
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Blood 
Blood conductivity is a function of haematocrit (percentage of red blood cells by 
volume), temperature, velocity/shear rate (effect depends on many secondary 
variables including cell shape and frequency of shear rate), electrolyte/protein 
content and anticoagulant. Table 3.4.l gives values for various combinations of 
variables. 
Table 3 .4.1: Conductivity of blood for different combinations of variables. 
Ref. a F Source T Comments (Sim) (Hz) (oC) 
[23] .67 low Human 37±.l Haematocrit = 42% (normal), anticoagulant= ACD 
[23] .71 low Human 37±.1 Haematocrit = 42% (normal), anticoagulant= SC 
[23] .67 low Human 37±.l Haematocrit = 42% (normal), anticoagulant= EDTA 
[23] .63 low Human 37±.l Haematocnt = 42% (normal), anticoagulant= SH 
[23] 1.11 low Human 37±.1 Haematocrit = 20%, anticoagulant= ACD 
[23] 1.15 low Human 37±.l Haematocrit = 20%, anticoagulant= SC 
[23] 1.17 low Human 37±.1 Haematocrit = 20%, anticoagulant= EDTA 
[23] 1.10 low Human 37±.1 Haematocrit = 20%, anticoagulant= SH 
[23] .41 low Human 37±.1 Haematocrit = 60%, anticoagulant= ACD 
[23] .44 low Human 37±.1 Haematocrit = 60%, anticoagulant= SC 
[23] .40 low Human 37±.1 Haematocrit = 60%, anticoagulant= EDT A 
[23] .37 low Human 37±.1 Haematocrit = 60%, anticoagulant= SH 
[24] .338 1.6 k Dog 25.0 Flow direction, steady flow, shear rate= low, 54% 
[24] .369 1.6 k Dog 25.0 Flow direction, steady flow, shear rate = high, 54% 
[24] .330 1.6 k Dog 25.0 Shear direction, steady flow, shear rate= low, 54% 
[24] .310 1.6 k Dog 25.0 Shear direction, steady flow, shear rate= high, 54% 
[24] .348 1.6 k Dog 25.0 Transverse direction, steady flow, shear rate= low, 54% 
[24] .366 1.6 k Dog 25.0 Transverse direction, steady flow, shear rate= high, 54% 
[25] 9% lOk - 22 !:i,.cr p-p, sinusoidal flow, peak shear rate= 500 s·1, 0.3 Hz, 35% 
[25] 6% lOk - 22 !:i,.cr p-p, sinusoidal flow, peak shear rate= 500 s·1, 1 Hz, 35% 
[25] 2.6% 10 k - 22 !:i,.cr p-p , sinusoidal flow, peak shear rate= 500 s·1, 3 Hz, 35% 
[25] 0.9% 10 k - 22 !:i,.cr p-p , smusoidal flow, peak shear rate= 500 s·1, 7 Hz, 35% 
[26] 2% low - - %al°C, annroximate temperature dependence 
[27] .51 lOOk Human 37 Normal adult, neonatal and placental blood, 42% 
[27] .74 - Human - Reconstituted, time-expired bank blood, 42% 
[27] .81 25k Human - Haemodialysis patients, 42% 
Blood conductivity is constant with frequency to several hundred kilohertz [28]. 
Further blood conductivity data and permittivity data is given under the section 
entitled General Tissue Conductivity and Permittivity. 
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Myocardium 
Myocardium conductivity is a function of blood conductivity, cardiac phase, tissue 
ischemia/death, temperature and frequency. Table 3.4.2 gives bulk transverse and 
longitudinal values, or isotropic values for various combinations of variables. 
Table 3.4.2: Myocardium conductivity for different combinations of variables. cr1 = 
conductivity in direction of muscle fibres, O't = conductivity in direction transverse to 
fibres. Numerical values of complex impedance are given in conductivity units. 
Ref. 0"1 O"t F Source T Comments (Sim) (Sim) (Hz) (DC) 
[291 .317 .202 5k Dog 37 average over cardiac cycle, in vivo 
[29] .339 .211 10 k Dog 37 average over cardiac cycle, m vivo 
[29] .356 .217 15 k Dog 37 average over cardiac cycle, in vivo 
[291 .369 .223 20k Dog 37 average over cardiac cycle, in vivo 
[29] .395 .234 30k Dog 37 average over cardiac cycle, in vivo 
[291 .416 .242 40k Dog 37 average over cardiac cycle, in vivo 
[291 .438 .250 50k Dog 37 average over cardiac cycle, in vivo 
[29] .457 .248 60k Dog 37 average over cardiac cycle, in vivo 
[291 16% 10% 5k Dog 37 Standard deviation 4 dogs, in vivo 
[29] 5% 3% 5k Dog 37 1:!,.cr p-p over cardiac cycle, in vivo 
[30] 3% = cr1 5-60k Dog 37 !!,.a peak, transient increase in blood cr, m vivo 
[31] .65 = cr1 lk Sheep 37 normal, in vivo 
[31] .22 = cr1 lk Sheep 37 60 min. after mfarct, in vivo 
[31] 1.11 = cr1 lk Sheep 37 1 week after infarct, m vivo 
[31] .98 = cr1 lk Sheep 37 2 weeks after infarct, m vivo 
[31] 1.35 = cr1 lk Sheep 37 6 weeks after infarct, in vivo 
[32] .14 = cr1 lk Dog 35 40 min. ofischemia, freshly excised, cr=l/Re(Z) 
[32] .15 = cr1 lOk Dog 35 40 min. ofischemia, freshly excised, cr=l/Re(Z) 
[32] .22 = cr1 lOOk Dog 35 40 min. of ischemia, freshly excised, cr= 1/Re(Z) 
[32] -4.44 = 0"1 lk Dog 35 40 mm. ofischemia, freshly excised, cr=l/Im(Z) 
[32] -1.31 = 0"1 10 k Dog 35 40 min. of ischemia, freshly excised, cr= 1/Im(Z) 
[32] -.69 = 0"1 lOOk Dog 35 40 mm. ofischemia, freshly excised, cr=l/Im(Z) 
[32] .06 = 0"1 lk Dog 35 90 min. ofischemia, freshly excised, cr=l/Re(Z) 
[32] .10 = 0"1 IOk Dog 35 90 min. ofischemia, freshly excised, cr=l/Re(Z) 
[32] .20 = cr1 100 k Dog 35 90 min. ofischemia, freshly excised, cr=l/Re(Z) 
[32] -.42 = cr1 lk Dog 35 90 min. ofischemia, freshly excised, cr=l/Im(Z) 
[32] -.25 = cr1 IOk Dog 35 90 min. of ischemia, freshly excised, cr= 1/Im(Z) 
[32] -.37 = 0"1 lOOk Dog 35 90 min. ofischemia, freshly excised, cr=l/Im(Z) 
General Tissue Conductivity and Permittivity 
Table 3.4.3 and Table 3.4.4 are extensive tables of conductivity and permittivity 
values respectively for a wide variety of tissues including fat, liver, lung and bone. 
The effect of permittivity is considered as negligible in this thesis. Other reviews of 
multiple tissues have been compiled [33-38]. Other detailed studies of single tissues 
have been compiled for instance for blood [39,40] and skeletal muscle [ 41]. 
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3.5 Heart Anatomy and Physiology 
This section will focus on humans with and without pulmonary hypertension. The 
section will start with a discussion of myocardium fibre orientation, fat distribution 
and respiration. Finally blood flow and more general relevant anatomy and 
physiology will be presented. This section, together with Section 3.4 is the most 
critical in the entire literature review. The typical investigator may totally neglect 
such content, making ad hoe assumptions, with no one questioning such an approach 
or actually praising it. All methods in the investigation chapters of this thesis are 
based on numerical modelling. Knowledge of variables and their variability between 
patients is crucial if numerical modelling is based on imaging of a limited patient 
population under limited conditions. It allows assumptions used in numerical 
modelling to be objectively assessed, as little information is generally included in 
models, due to lack of readily available information on relevant aspects of heart 
anatomy and physiology. An investigation into a small aspect involves many years of 
research. More questions are raised in this section than are answered in this thesis. 
The importance of this data to the thesis and the complexity in conveying the 
information warrant the length of this section. The approach used in this thesis is 
therefore significantly different from previous conductance catheter techniques. 
Myocardium Fibre Orientation 
Fibre orientation effects both how the heart pumps blood and how electric current 
interacts within the thorax. Figure 3.5.1 shows the general muscular structure of the 
heart. The fibre direction is relatively uniform across the heart, but varies 
significantly with depth. The ventricle muscle longitudinal direction is 
circumferential in the short axis plane at approximately halfway between 
endocardium and epicardium. The angle of fibres increases relative to the short axis 
plane to become around 60-90 (90 degrees at the trabeculation) degrees at the 
epicardium and endocardium. The direction towards the endocardium is in a left to 
right direction :from the apex to the base, whereas the direction towards the 
epicardium is in a right to left direction from apex to base. The fibre angle from 
histological dissections of dogs is shown in Figures 3.5.2. Such findings are in 
accordance with diffusion tensor MRI studies, Figure 3.5.3. The fibres of the heart 
muscle have been found to be arranged in sheets 4-6 cells thick, separated by 
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collagen matrix as shown in Figure 3.5.4. The normal angles of these sheets can also 
be measured using the above techniques as shown in Figure 3.5.5. Therefore 
properties of heart tissue are expected to be different in three mutually orthogonal 
rather than the two transverse directions orthogonal to the fibre direction being equal. 
To the best of my knowledge the inter-animal and inter-species variability of the 
fibre direction has not been assessed in detail as yet. 
A ORIENTATION OF' MYOCAROlAL FIBERS IN Tri( V'(NTRICULAR W~L~5 
• 
TRICU AR 'uSCULAT v ( 
Figure 3.5.1 : Muscle architecture of the heart. [42]. 
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Figure 3.5.2: Transmural distribution of fibre orientation from histological studies. 
[43]. 
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(a) (b) 
Figure 8. (a) A colour map represent ing t he fibre a ngle in the myocardium as determined from 
high-resolution 3D diffu ion ten or imaging with fast spin-echo. T he blue r presents a fi bre 
angle of -60° off the circumferential and red a 90° angle. The tran mural gradient in fibre angle 
is clearly seen. (Data courtesy of David Scollan and Rai W inslow.) (b) A single lice from a 
high-resolution 3D Tl weighted image of a dog heart in vitro. Fine vascular and fibre structures 
are visible. 
Figure 3.5.3: Fibre direction from diffusion tensor MRI. [44]. 
A 
(a ) 
... -----
----
(a) B 
(b) 
Figure 2 (A) Schematic showing (a) the vari ation in musc le fi ber di rection across the 
wa ll in a segment removed from the left ventricle, and (b) the bra nching laminar structure 
of myocardium in which the sheets are composed of myocytes bound in layers. 3-4-cells 
thick, by endomysial collagen and surrounded by perimysial co ll agen, which also links to 
the adj acent sheet. This " fibrous-sheet" architecture allows for shearing to occur between the 
layers and aids the process of wall thickening at end-systole. (8 ) (a) A composite 3-D confocal 
image of a transmural block of myocardi al tissue from the rat heart with a single image slice 
shown below; (b) a fi nite element model of the cleavage planes fro m the transmuraJ tissue 
block used to study the Aow of current and propagation of the tissue activation wave front 
around the myocardi al sheet structures. The spatial variation of tissue properties, such as 
the density of collagen, gap junctions, and ion channels, is defined by the markup language 
FieldM L (http ://www.bioeng.auckland.ac.nzlphysiome/physiome. php). Note: A and B from 
Hooks et al. (75) by permission. 
Fig 3.5.4: Fibres arranged in sheets separated by collagen. [ 45]. 
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Figure 10 (A) Map of primary eigenvector inclination angle obtained from DTMRI forone 
slice in a fixed rabbit heart . (8) Fiber inclination angle map obtained from the hi tological 
reconstru tion of iclscn et al (77) for one section of a dog heart. (C) Map of tertiary 
eigenvector inclination angle obtained from DTMRI for the same slice as in A. (D) Map of 
the inclination angles of the laminae normals obtained from the iel en et al reconstruction 
for the same slice as in B. 
Figure 3.5.5. Fibre direction (top) and fibre sheet direction (bottom) from diffusion 
tensor MRI (left) and histological studies (right). [ 46]. 
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Fat Distribution 
As well as affecting the dynamics of the heart, fat (or more precisely adipose tissue) 
surrounding the heart affects how electric current interacts between heart and thorax. 
We are specifically interested in the distribution and variability of the distribution 
between subjects. There are three main types of fat considered here, epicardial 
(attached to surface of the heart), intramyocardial (infiltrating myocardium) and 
pericardia!. 
Figure 3.5.6 shows the epicardial fat distribution across the normal right ventricle. 
The measurements are the mean epicardial fat thickness in mm at the ten different 
sites from a study of 200 autopsy patients, mostly males over the age of 40. 
Epicardial fat spreads inwards from the base of the heart and the coronary 
artery/sinus areas. There is decreasing level of fat from base to apex, relatively thick 
fat on the anterior wall of the right ventricle and relatively non-existent fat on the 
diaphragmatic/posterior surface of the ventricle. Table 3 .5 .1 gives the corresponding 
standard deviation and variance at the ten sites on Figure 3.5.6. Significant variability 
between patients is indicated. The thickness distribution of the 2000 (200x 10) 
measurements taken is shown in Figure 3.5.7. Figure 3.5.8 shows findings from a 
different study at position equivalent to 5 and 8 in Figure 3.5.6. A significant 
increase in fat with age is shown but other studies don't support this [89] The 
epicardial fat in women has been found to be significantly greater than that in men, 
in those aged over 20 [ 48]. Patients with hypertrophied hearts have been found to 
have more epicardial fat, however the ratio of fat to myocardial mass in each 
ventricle has been found to be relatively constant even in hypertrophied hearts [89]. 
The amount of epicardial fat seems to be more related to the amount of visceral fat 
than total fat [89]. Little has been published on the distribution of fat on the left 
ventricle [90], however it has been reported to be about one third of the right 
ventricle per gram of myocardium [89]. 
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Figure 3.5.6: Typical epicardial fat distribution over the right ventricle free wall. 
Base (top), apex (bottom), surface adjacent liver (left), surface adjacent sternum 
(right), pulmonary artery (top right). Measurements are mean thickness in mm. [ 47]. 
Table 3.5.1: Mean (X:), and standard deviation (s) of epicardial fat thickness (mm) at 
the sites (1 -10) marked in Figure 3.5.6. [47]. 
Tab.2 Durchschnittswerte der epikardialen Fettschichthohe an 
den 1 O StandardmeBstellen. berechnet von je 200 Einzelwerten 
MeBstelle x s $2 
1 2.913 2.498 6.242 
2 4.12 2.598 6.751 
3 1.234 1.668 2.783 
4 1,882 1.518 2,305 
5 2.788 2.069 4.279 
6 0.851 1,393 1.94 
7 1.71 1.44 2,073 
8 2.529 2.006 4.025 
9 1.34 1.838 3.38 
10 2.852 2.058 4.236 
---
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Figure 3.5.7: Thickness distribution showing number of measurements from all ten 
measurement sites within a certain mm out of a total of 2000 measurements. [ 4 7]. 
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Figure .2. Thickness of epicardial fat in lateral right ventricle wall by 
age. The amount of epicardial fat in the right ventricle increased with 
age. Infants had little or no epicardial fat: the greatest amount of fat 
was seen in subjects over 40 years of age . 
Figure 3.5.8: Epicardial fat thickness with age. [ 48]. 
The border between epicardial fat and myocardium can be well defined or ill-
defined. Ill-defined borders are usually associated with intramyocardial fat. In most 
cases intramyocardial fat is located in the outer one half of the myocardium. It's 
distribution is similar to the epicardial fat distribution [48]. Figure 3.5.9 shows the 
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proportion of right ventricle myocardium that is fat in the normal heart. There is a 
significant increase with age and in females aged over 40 [ 48]. 
0 0-19 years • 20-39 years • > 40 years 
6-15 16-25 26-35 36-45 46-55 
% intramyocardial fat 
figure 6. Males: % intramyocardial rat in lalcral rii:hl ventricle wall 
by age. In male subjects the amounl or intramyocardial rat in lhe 
lateral rii:hl ventricle increased with aiw. with the largcs1 amounts or 
inlramyocardial fal seen in the over 40s. 
D 0-19 years 112()-39 years • > 40 years 
% inlramyocardial fat 
Figure 7. Females: % intramyocardial rat in lateral righl ventricle 
wa ll by age. Female subjects i:cnerally had more inlramyocardial ra1 
lhan males. The amount or rat in the lateral right ventricle wall 
increased with age: in one-third or remales over 40 years or age over 
50% or the lateral wall was replaced by rat 
Figure 3.5.9: Percentage of myocardium that is intramyocardial fat. Males (top) and 
females (bottom). [ 48]. 
The inner surface of the parietal pericardium has no fat and is in direct contact with 
the heart, however fat exists on the epipericardium. Epipericardial fat is usually most 
prominent adjacent the right ventricular free wall [ 49]. The amount of epipericardial 
fat varies significantly between subjects, approximately half with an insignificant 
quantity. A collection of epipericardial fat typically exists around the anteroinferior 
portion of the heart pericardium [50]. Presence of epipericardial and epicardial fat 
allow identification of the pericardium on CT and MRI scans over the right ventricle 
[51]. There is typically little fat between base of the pericardium and liver. The 
anterior surfaces of the lungs are in direct contact with the chest wall, with no fat in 
between [50]. However they may be restricted from extending around the anterior of 
the heart by epicardial fat. 
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Respiration 
As well as translating, the heart undergoes deformation and rotation due to 
respiration [52-58] that is unrelated to respiratory changes in stroke volume. 
(Mechanical attachment of the pericardium and heart in humans and stroke volume 
changes were discussed in Section 2.2). Studies have shown significant inter-subject 
variation in heart deformation due to respiration. Typical values for heart landmark 
movement between deep inspiration and expiration are shown in Table 3.5.2. The 
approximately linear proportionality between diaphragm movement and the 
landmarks is given in Table 3.5.3. The largest movement is in the inferior direction 
with increasing inspiration. As can be seen, inferior points move a greater amount 
than superior points of the heart. 
Table 3.5.2: Heart landmark movement with respiration. [52]. 
, Table i 
' SI Displacements Compared with AP Displacements 
Anatomic Landmark - Coordinate Type Range (mm) Sl/AP Range Ratio 
Heart Si (inferior margin) 18.1 :!: 9.1 10,3 :!: 9.1 
AP (anterior margin) 2.4 ::!; i .5 
Apex SI 16.0 :!: 7.i 10.6 :!: 7.7 
AP 3,0::: 2.8 
RCA root SI 10 5 :!: 4.8 6,2 :!: 3.6 
AP / 23 :!: i.4 
LAD SI 13.1 :!: 4.i 8.2 :!: 4.1 
i AP 2.0 :!: 0.7 
1 Motion range is taken to be the range of the measured coordinates. (Notation. mean :.: standard dev1at16n over 1 O subjects.) 
L------~---- ------~ - - -- - --- ~- -- - .. ~ 
Table 3.5.3: Relation between landmark movement and diaphragm movement. [52]. 
~- -- --- --- ---- - -- -
: Table 2 -
i Linear Regression with Respect to the SI Position of the Diaphragm 
Anatomic Landmark 
Cardiac superior margin (i ,5) 
Cardiac inferior margin (1,5) 
RCA root (1,5) 
Apex (2,6) 
LAD (2,6) 
Regression Slope k 
0.62 :!: 0.19 
0.92 = 021 
·-'0.57 :!: 0 26 
0.81 :!: 0 23 
0.70 :!: 0.18 
Correlation Coefficient r 
0.96 :!: 0.04 
0.98 :!: 0.01 
0.97 :!: 0.03 
0.97::: 0.02 
0.98 ='= 002 
: {Notation: mean :!: standard deviation over 10 subjects; the numbers in parenthesis In the first column reference to figures) 
Mechanical ventilation and posture have been found to significantly affect 
diaphragm and rib motion [104]. Posture also affects static diaphragm position. 
These variables would therefore be expected to cause deformation of the heart. 
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Blood Flow 
The main cardiac performance indices (cardiac output, stroke volume, heart rate and 
ejection fraction) give little information about the temporal dynamics and 
distribution of blood flow around the heart. In this section, results from MRI phase 
velocity imaging studies are presented to give greater insight into blood flow around 
the heart. This technique is often used to validate heart fluid dynamics modelling 
[59]. MRI velocity provides accurate flow integrals [60, 61]. 
Figure 3.5.10 shows the flow curves (integrated from MRI velocity normal to planes) 
for various vessels close to the heart. The data is from a normal person at rest and 
during upright cycling exercise. The heart rate increased by 54% between rest and 
exercise. Note the more steady flow in the inferior (E) and superior (D) vena-cava 
compared to the main (A), left (C) and right (B) pulmonary artery. 
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Figure 3.5.10: Pulmonary and Cava Flow in Normal Person. [62]. 
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In Pulmonary hypertension there is a significant change in the flow curves in the 
pulmonary artery. Figure 3.5.11 separates forward flow from reverse flow, forward 
flow and net forward flow (forward flow minus reverse flow). As can be seen there is 
negligible reverse flow (mainly around the time 400ms at pulmonary valve closure) 
in normal patients (A) but significant reverse flow in pulmonary hypertension (B). 
The reverse flow is suggestive of strong velocity profile differences across the 
pulmonary artery, in the case of pulmonary hypertension. This reverse flow results in 
a double peak waveform of net flow. 
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Fig. 5. ·Mi<! pulmonary aI:tery'tlow in a normal subject (A) and in a patient with pulmonary arterial hy-' 
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Figure 3.5.11 Normal (A) and Pulmonary Hypertension (B) Flow Waveforms in the 
Pulmonary Artery. Solid square= net forward flow, diamond= reverse flow, cross= 
forward flow. [63]. 
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Figure 3.5.12 shows the velocity profile in the normal pulmonary artery. It has a 
consistently skewed mean temporal velocity profile (not shown) with a well-defined 
low flow region located to the inferior right. 
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Fig. 2. Typical example (volunteer 1) ofthree-dimen ional visualization of temporal and spatial develop-
ment of velocity profile viewed from downstream position. Top left, time in cardiac cycle is indicated on 
mean velocity curve with time interval relative to R wave in recorded electrocardiogram (milliseconds). 
Anatomic orientation shown in velocity profile a is used in successive plots. a, Beginning of cycle; b and 
c, acceleration phase; d and e, peak systole; f, g, and h, deceleration phase; i, diastole. 
Figure 3.5.12: Normal pulmonary artery velocity profile throughout the cardiac 
cycle. [ 64] . 
Figure 3.5.12 gives no indication of the distensibility of the pulmonary artery. 
(change is cross sectional area of flow with cardiac phase). Figure 3.5.13 shows both 
the cross sectional area and velocity distribution in the pulmonary artery. The white 
circle represents the perimeter of the pulmonary artery. As can be seen in (A) the 
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cross sectional area of the pulmonary artery changes significantly during the cardiac 
cycle of a normal individual. As in Figure 3.5.12 and Figure 3.5.11 the flow profile is 
relatively uniform forward flow throughout the main part of the cardiac cycle (white-
blue), with little reverse flow (red). While the larger cross sectional area appears 
relatively constant in (B) pulmonary hypertension, a highly heterogeneous reverse 
flow (red) is present as suggested by Figure 3.5.11. Numerical data is given in Table 
3.5.4. 
Figure 3.5.13 : Normal (A) and pulmonary hypertension (B) velocity profiles in 
pulmonary artery throughout cardiac cycle. White circle = perimeter of pulmonary 
artery. Blue = forward flow, Red= reverse flow. [65]. 
Table 3.5.4: Normal and pulmonary hypertension pulmonary artery velocity and 
cross sectional area data. [ 65]. 
TABLE 2 
DIFFERENCES IN MAGNETIC RESONANCE PARAMETERS 
BETWEEN PATIENTS WITH PRIMARY PULMONARY HYPERTENSION 
AND HEAL THY SUBJECTS* 
Main Pulmonary Artery Patients Volunteers p Value 
Maximal antegrade velocity. cm/s 60 ± 20 79 ± 18.4 < 0.005 
Maximal mean velocity. cm/s 34.8 ± 13.06 55 ± 15.2 < 0.005 
Maximal surface, cm' 10.5 ± 2.8 8.2 ± 0 .9 < 0.05 
Minimal surface, cm2 9 .5 ± 2.6 6 .5 ± 0.8 < 0.005 
Mean surface, cm2 10.1 ± 2.7 7.3 ± 1 < 0.005 
Nmonary distensibility, % 13 ± 7.07 23.8 ± 6.1 < 0.0005 
Acceleration time, ms 93.46 ± 22.5 153.2 ± 19.2 < 0.0005 
Maximal retrograde velocity, cm/s 35 ± 14.3 24 ± 5.4 < 0.05 
Regurgitation fraction, % 22.9 ± 10 7 .46 ± 4 < 0.0005 
Maximal velocity/mean velocity 1.84 ± 0.56 1.45 ± 0.16 < 0.05 
' Results are expressed as mean ± SE. 
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One of the main methods for evaluating pulmonary hypertension is assessment of 
tricuspid regurgitation using ultasound. Figure 3.5.14 shows the difference between 
flow measured by integrating MRI velocity and flow measured by MRI ventricular 
volume changes. Even considering error it seems reasonable to conclude that 
measurement of flow based on ventricle volume is overestimated in pulmonary 
hypertension. 
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Figure 3.5.14: Difference between flow measured by integrating MRI velocity and 
flow measured by MRI ventricular volume changes. Controls are normal. [66]. 
For the same pulmonary hypertension patients, Figure 3.5.15 shows the difference 
between thermodilution derived flow and MRI velocity derived flow showing 
reasonable agreement between the two (within the known error of the thermodilution 
method). 
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General 
Figure 3.5.16 shows the change in cross sectional area inside the pericardium 
between systole and diastole. As can be seen, the largest change in cross sectional 
area occurs at the base end of the ventricles. There is relatively little change at the 
apex. 
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Figure 3.5.16: Cross sectional area inside the pericardium at end diastole/end systole. 
[67]. 
The difference between end systole and end diastole pericardium volume is due to 
more outflow of blood than inflow over the period of time from end-diastole to end-
systole. Instantaneous and cumulative blood inflow and outflow is shown in Figure 
3.5.17. As can be seen, the total heart volume difference between end systole and end 
diastole is around 1 OOml. 
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Figure 3.5.17: Volume flow into and out of heart during the cardiac cycle. [67]. 
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Figure 3.5.18 shows the changes in ventricle blood cavity dimensions during the 
cardiac cycle. The slopes of these graphs indicate how volume change through the 
cardiac cycle of the left ventricle is mainly due to cross sectional area change of the 
blood pool, whereas volume change of the right ventricle is more due to length 
changes in the blood pool. 
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Figure 3.5.18: Changes in ventricluar blood pool dimensions through cardiac cycle. 
[42]. 
Normal end systolic and end diastolic ventricular volumes in rest and supine exercise 
from very high speed MRI are given in Table 3.5.5. The figure shows relatively 
constant end-diastole ventricle volumes between rest and exercise, but the relatively 
large decrease in end-systolic volumes with exercise. Also the left ventricle has a 
higher ejection fraction than the right ventricle. 
Table 3.5.5: Ventricular volume at end systole and end diastole during rest and 
exercise. [68]. 
'TABLE4 LV aria RY Ch~nges from Rest lo· S!ress - . 
43ft Venlride . Rig~t Vent~ide 
Rest-. Exercise Change(%) Rest Exercise Change[%) 
EntWiostolic volume (ml) 143 29 ~ 138"' 27 .. -3.3:?: 5-· 144 17 144 :!: 24 -06= 8 
EntWiostohc volume index !ml/ min2 ) 79 9 75'1:-9 79 9 79 !:. 7 
End-s)lslolic volume (ml) ·' 5~ 17 - 36':;: 12• "...:3·2-.6',.:!: 12 58 17 43 = 13* -253=12 
End-.Ystohc volume index. (ml/ min2) 29 7 20 :!: 5* 32 7 24 :!: 6.* 
Stroke volume (ml) · 99. 14 102 ±319* +'14.3 ± 8 .88 14 101 :!:.16* -154 :!: 9 
Stro~e volume inaex (ml/min2 ) ,49 6 ·- 56 ~ 6* 49 6 56 ± 5* 
Ejectton froctton (%) 63 6 74-= 6* + 18.3,:!:·7 61 6 70:!: 6* +16.6 :!: 8 
Cord1oc outpvt (l/min) 6.3 .1.0 12.3' :!:,2:3• -i-97.5 :!: 1'4 6.2 1.0 12:0 :!: 2.1· .;.994 :!: 13 
!=ordiac_inc(ex (l/min'(m2 1, 3,.5 0.4 - . 6;8 :!:.0.8* . . ' 3.4 0.4'. 6?'.:!: 0.6*' 
'Si9n1~cont chon9e"from resl to •tress, p <0.05. _, 
"' 
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Typical movement of the normal (no right ventricular overload) heart base between 
atria and ventricles from M mode ultrasound is shown in Table 3.5.6. The mitral 
annulus shows significantly less displacement than the tricuspid annulus. There is a 
significant change in displacement across the septum. 
Table 3.5.6: Heart base displacement. [69]. 
--
' Table 1 Total excursion and that attributable to anial contraction-relaxation (a) are listed for tri~pid and 
: mirral annular monon in 10 normal subjects and 29 patients with no signs of right-sided heart disease 
Tncuspid auulus 
Lateral point 
Septa! point 
Anterior point 
Posterior point 
Mirnil anulus 
Lateral point 
Septa! point 
Anterior point 
Posterior point 
Total 
excursion 
24-.9 ± 3 5 
20.l ± 2.5 
21.6 ± 3 8 
22.3 ± 2.3 
17.8 ± 4-.0 
14.6 ::!: 2.7 . 
15.7 :!: 2 7 
16.8 ± 2.6 
Normal subjects 
Atrial 
contractfon-~n 
7.3 ± 1.9 
6.3 ± 2.1 
7.7 ::!: 2.7 
6.8 ± 1.9 
5.7 ± 1.6 
5.9 ± 1.2 
5.2 :!: 1.4 
5.7 :!: 1.3 
Nwnbcts o.rr exp~ in mtllimctcrs :!: l mndard dcviorion. 
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Total 
21.9 :!: 2.7 
15.8 ± 3.6 
18.6 ± 4.8 
19.l ::!: 3.6 
12.6 ± 2.8 
11.4 :!: 2.5 
12.2 ± 3.2 
12.5 ± 3.0 
Patients 
Atrial 
con11'3Cdon-rebxation 
8.6 ::!: 2.8 
6.7 ± 2.8 
8.0 ± 2.8 
8.2 ± 2.6 
5.3 ± 1.7 
4.9 ::!: 1.4 
4.9 ± 1.4 
5.1 ± 1.6_ 
The normal size of the aortic and pulmonary valves are given in Table 3.5.7 and the 
normal and abnormal sizes of the tricuspid and mitral valves are given in Table 3.5.8. 
Table 3.5.7: Normal aortic and pulmonary valve size at autopsy. [70]. 
TABC.E II P.,ean Values for Aortic and Pulmonary Valve 
Dimensions' · 
Aortic Pulmonary 
: Circumference (cm)• 7~63 ± 0.93 overall 7.28 ± 0~92 
Male 1.56 ± 1.04 "t.77 ± 0.98 
Female 6.80.± 6.89 ·7.32 ± 0.86 
Area·(cm2) 
4.56± 1.12 4.71±1.16 Overall 
Male 4.81±1.30 4.88 ± 1.25 
Female 3.73 ± 0.98 4:32 ± 1.03 
Diameter (mm) 
Overall 23,·20 ± ,3.3 ?!t.3Q ±·:rn 
Male 23.80 ± 3:3 24.70 ±·3.1 
Female 21.60 ± 2.8 2.~.30 f 2.7 
• Primary valve measurement. Area and diameter derived by cal-: 
culation. 
Values are mean ±·standard deviation. 
Table 3.5.8: Normal tricuspid and mitral valve size at autopsy. [70]. 
f~SLE I Me~n V11.Jues for Mitral and :rricLispid Dimensions with and without Congestive He11.rt Failure (CHF) 
WithoutCHF WithCHF Overall 
Mitra! Trisc.uspi~ Mitra I ·Tricuspid M1tral 
circumference.(cin). 
·9:79 ± 1.23 11.63± 1.39 10.46 ±-1.26 12.22 ± 1.43 10.05 ± 1.28 overall 
Male 10.15 ± 1.24 11.95±.1.26 10.68 :!: '1.26 12.48 :!: 1.44 10.38 :!: 1.27 
Female 9.,1,1 :!: 0.86 10.40 :I; 1.06 9,71 :!: 1.00 11.46:1:1.14 9.29 ±0.94 
p.rea (crn2) 
7.76 :!: 1.93 10.56 ± 2.59 8.83 :!: 2.12 12.05 :!: 2.87 · Overall 8 17 ± 2.07 
Male 8.33 ± 1.98 1'1'.50:!: 2.46 9.21 :!: 2.13 12.56 :!: 2.94 8.70± 2.08 
Fem!lle . 6~,66 £ 1·:26 8.75 ±'1.74 7.58 :!: 1.55 10.54 :!: 2.07 6,94 :!: 1.41 
Diameter (mm) 
31.1±3.9 Overall 36.4 :1:·4_4 33.3 ± 4.0 38.9 :!: 4.6 32.0 ± 4;0 
Male 32.3±3.9 38.0 :!: 4.0 34.6 ±4.o 39.7 ± 4.6 33.0 :!: 4.0 
female' ~29._0 ± 2.7 33.2 :!: 3.3 30:9 ::f: 3.1 36.4 :!: 3.6 29.6 :!: 3.0 
• Primary valve meai;urement. Area and diam~ter derived by calculation. 
Values are mean :!: standard· d13viatiori. 
Autopsy (fresh) results show increased valve dimensions relative to maximum 
echocardiography dimensions [105]. Larger tricuspid valve dimensions are 
associated with tricuspid regurgitation [105]. The tricuspid valve changes 
circumference and area during the cardiac cycle with a reduction in area of 
approximately 33% (±4%SD) in normals and 18% (±4%SD) in tricuspid 
regurgitation [105]. 
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:rricuspid 
11.74 :!: 1.45 
12 i2 :!: 1.36 
10.77 :!: 1.18 
11 .. 14 :!: 2:79 
11.90 :!: 2.72 
9.33 ± 2~02 
37".3 ±,4;6 
38.8 :!: 4'.3 
34.3 :!: 3.6 
Figure 3.5.19 shows the distribution oflongitudinal displacement of the left ventricle 
between base and apex for both normal and right ventricle pressure overload. The 
longitudinal shortening is approximately constant from apex to base. Right 
ventricular overload is associated with significantly less longitudinal shortening. 
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FIG 3. Gr:aph showing- relations l::)etween the longi~udinal sys-
tolic descent of the tags and their end-diastolic distance from 
the epicardial apex for healthy subjects- and for patients with 
chronic nght ventricular -prei?sure overload (RVPO) (averaged 
· data of four different circumferential regions). Nete that there , 
'. were very good linear descent-distance relations for both sets of . 
: data and that the slope of the-relation ih the patient group was · 
, Significantly less than th~t ii::l healthy subjects (0.13 Vs 0. 18, 
. P<.005), indicating that the longitudinal shortening in patients 
~ith RV£?0 ~_c:is le_~s !h.an_t~~!_i_n healt~y_s~bj~ct~_. _ _ _______ J 
Figure 3.5.19. Longitudinal displacement of the left ventricle towards apex during 
systole. [71]. 
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As shown in Figure 3.5.20, the left ventricle circumferential shortening in the 
epicardium is small in both normal and right ventricular overload, compared to 
endocardium shortening. Right ventricular overload is associated with less 
circumferential shortening than normal. 
Ant Lat Post Sep 
- ----------- - --1 
Epicardium J 
!SE)RVl'O 
ONonnal 
f r1i· -·· •• WmQij_cSsh_Lll~L- : 
Ant Lat Post Sep 
F1G 8. Bar plots showing the averaged endocardial (left) and 
epicardial (right) circumferential shortening fraction in different 
regions. Compared with the values of healthy control subjects, 
the endocardial shortening fraction of the septum and lateral wall 
decreased significantly in patients with chronic right ventricular 
pressure overload (RVPO), whereas no significant differences 
were seen in the anterior and posterior regions between the two 
groups. *P:5.05, endocardial or epicardial shortening of RVPO 
patients vs those of the healthy subjects; +P<.05, endocardial 
shortening of the septum vs the other three regions in RVPO 
patient; **P<.05, shortening of epicardium at posterior wall and 
right surface of the septum vs the anterior region in healthy 
subjects; and + +P<.05, epicardial shortening of the posterior 
wall vs the lateral region in RVPO patients. Ant indicates anterior; 
Lat, lateral; Post, posterior; and Sep, septa! regions of left 
ventricle. 
Figure 3.5.20. Left ventricle circumferential shortening fraction during systole. For 
different positions around the ventricle. [71]. 
As shown in Figure 3.5.21, the thickness of the left ventricle myocardium in right 
ventricular overload is greater than normal. However, the absolute and :fractional 
thickening is reduced. The large value of the fraction thickening is due to the fibre 
structure of the myocardium [72]. As discussed previously, the myocardium fibre 
direction is in every direction, but primarily tangent to the wall, not in a normal 
direction. Conservation of volume means that if muscle contracts in one direction it 
must expand in another. Due to fibre architecture it cannot expand in a tangent 
direction and therefore thickness changes occur in the radial direction. 
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F1G 6. Bar plots showing the average end-diastolic thickness, 
absolute thickening, and thickening fraction of patients with 
chronic right ventricular pressure overload (RVPO) (shaded bars) 
and healthy subjects (open bars) at anterior (Ant), lateral (Lat), 
posterior (Post), and septa! (Sep) regions of the left ventricle. The 
thickness was greater in RVPO patients than in healthy subjects, 
but the difference was significant only in the septa! region. 
However, the thickening fraction in patients with RVPO was 
significantly less than that in the healthy subjects at each region, 
whereas there was no difference in absolute thickening between 
healthy subjects and RVPO. 
Figure 3.5.21: Left ventricle myocardium thickness and thickening. [71]. 
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As can be seen in Table 3.5.9 the wall curvature is uniform around the normal left 
ventricle. However in right ventricle overload the curvature is reduced in the septum 
relative to other locations around the wall. 
Table 3.5.9: Wall curvature ofleft ventricle. [71]. 
TABLE 3. Changes in Regional Curvatures of the Left Ventricle in Patients With RVPO 
; Compared With Those in the Normal Subjects 
Normal Subjects RVPO Patients 
End Diastole End Systole End Diastole End Systole 
Circumferential curvature 
Antenor 0.038:!:0.001 0.049:!:0.003 0.043:!:0.003t .0.057:!:0.005t 
Lateral 0.040:!:0.002 0.056:!:0.003 0.036:!:0.002 0.041 :!:0.003" 
Posterior 0.038:!:0.001 0.049:!:0.002 0.040:!:0.002:j: 0.050:!:0.003:j: 
Sept al 0.04Q:!:0.002 0.049::!:0.003 0.030::!:0.001. 0.029:!:0.006* 
P=NS P=NS P< 005 P<.001 
Meridional curvature 
Antenor ·0011±0.005 '0.014±0.005 0.014::!:0.Q02 0.013:!:0.002 
La~eral 0.012:!:0.002 0.017:!:0.008 0.013:!:0.002 0.010::!:0.002 
Posterior 0.013:!:0.003 0.014:!:0.004 0.007 :!: 0.002§ 0.011 :!:0.003 
Septa! 0.011 :!:0.003 0.010:!:0.003 0.009:!:0.002 0.013:!:0.004 
P=NS P=NS P<.05 P=NS 
RVPO md1cates right ventricular pressure overload. Values are mm-1• 
"P<.005 compared with the normal subjects. tP<.05 compared with lateral and septa! regions and :j:P<.005 compared 
witti septa! region in the circumferential curvature in the R\i'PO patients. §P<.05 compared with the ant13rior and lateral 
regions in the meridional curvature in th~ RVPO patients. 
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So far only left ventricle dynamics have been discussed. Normal right ventricular 
displacement towards apex during systole is shown in Figure 3.5.22. Considerable 
longitudinal basal displacement of the free wall decreasing smoothly towards the 
apex is indicated. 
19.22 
0.0 
(a) (b) Time1 
(c) Time2 (d) nme3 (e) Time 4 
Figure 13. Normal heart displacement ttvough systole shown as a color plot on the RV endocardial free wall. The paths 
of points located in the centers of the elements are shown from end diastole (white) to end systole (blue). 
Figure 3.5.22: Right ventricle longitudinal displacement. [73]. 
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The heart undergoes slight torsion relative to the base. Average torsion about the left 
ventricle long axis is shown during systole for base, midsection and apex, of the right 
ventricle, septum and left ventricle, in Figure 3.5.23. Rotation is negligible at the 
relatively fixed base. Rotation increases from base to apex. 
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Figure 3.5.23: Average rotation of the heart. [74]. 
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The prev10us figure gives no indication of torsion across the ventricular wall 
thickness. Figure 3.5.24 shows rotation at the left ventricle epicardium and 
endocardium. There is greater rotation at endocardium than epicardium. 
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'FIGURE 5. ,Bar graph showing mean torsion angles of epi-
cardium a'!'l.' t:ndoc,ard4ufl f>f fiye 1'!/t v.eniricular slices 
(±SEM). Difference in torsion angles between ~bees is Signif- · 
ica!tt for _both f!picaf"t!ium (p~0,.001) find emlocardi_um . 
(p<OXJOJ). Endocar4ial torsii>rr-angles are g1:eater than epi-
cardia/ (p<(J.OOJ). 
Figure 3.5.24: Left ventricle epicardium and endocardium rotation. [75]. 
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Ventricular rotation is thought to help evenly distribute stress in the myocardium 
[76]. Figure 3.5.25 shows strong correlation between left ventricular torsion and 
endocardium radius in systole. 
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FIGURE. I. A-B" is the isovolumic relaxation phase and C-D- is the ejection phase. 
Note-that during ~je\:tfon, twist ang shortening (ch~nge in- mean r;idius) are linear; duri~g 
isQyol,umic ~~l_axati01;1, rapid ~~.ist ,recQil happ!!nS before lengthening; ABR: aortic;blood 
i;i.ressure; LVP: left-ventricular ,~ressurn·. Reproduced with permis_sion ifro,m"~eyar et'-az.2-6 
Figure 3.5.25: Correlation between left ventricle torsion and mean left ventricular 
radius in systole. [76]. 
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Table 3.5.10 shows general anatomic changes in the heart with pulmonary 
hypertension. As can be seen the right ventricular free wall thickens considerably and 
the septum also thickens slightly, with enlargement of the pulmonary artery in 
primary pulmonary hypertension. 
Table 3.5.10 Changes in heart dimensions associated with pulmonary hypertension. 
[77]. 
TABLE II Pulmonary Artery and Right-Ventricular Dimensions as Measured.by Magnetic 
Resonance Imaging 
2° PAH 
Norrf!al!? 1° PAH (LD) 
: Main RAD (cm~ 2.5±.0.4 3.9 ± o.5· 3.6±-o.5· 
Main PMasc. aorta 0.9 ± 0,2 -1.4·± 0.2· 1.1±0.1 
Desc. LPA/desc. aorta 0.4.± 0.1 1.1±0.3· 0.8 ± 0.1 .. 
RVWT(cm) 0.3 ± 0.1 -1.2 ± o.4· 0.6 ± ci.1 
SWT(cm) 1.0.± 0.1 1.2 ± 0.3· 1.2 ±<fa 
PWT(cm) 1.0 ± 0.1 1.1::;!:0.2 0.9 :i:j).-1 
• Significant difference compared with values in normal subjects. 
Values are mean± standard deviation. , 
2° PAH 
(Eisenmenger) p Vah,1~ 
3.7 ±·o.5· o.ci5 
1.4 ± o-.3~ 0.05 
1.0 ± 0.2· 0.0:1 
1.3 ± 0.3· 0.01 
1.3 ± o.~ 0.05 
1.0 ± 0.3 NS 
. Asc. =.ascending; ['.)esc. =descending; Desc. LPA =.descen9ing.left-pulmonary artery;·NS =not sig~ 
· nificant; PA = pull'.Tlonary arl;er:y; PAD = PA diameter; 1° and 2° PAH :;::: pfimary and secondary pu!nionary 
hypertension;.PWT = posteri9r-wall thickness of the 1.eft ventricle; BVWT = right ventricular wall thickness; 
SWT = ~e~tal_wall thi_cknes_s. 
68 
The wall thickness correlation with pulmonary artery pressure is shown in Figure 
3.5.26 
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Figure 3.5.26: Wall thickness correlation with pulmonary artery pressure. [77]. 
In pulmonary hypertension, the right ventricle also typically shows an increase in 
right ventricle end-diastolic and end-systolic volume. This results in a significantly 
reduced ejection fraction. This is shown in Table 3.5.11. Left ventricle end-systolic 
volume remains relatively constant, however stroke volume is reduced. The short 
axis MRI series in Figure 3.5.27 shows septum curvature in pulmonary hypertension 
at various stages through the cardiac cycle. At the start of systole, the septum is 
curved towards the right ventricle. Right ventricular systole is typically longer than 
left ventricle systole. As a result, the high right ventricle pressure typically causes the 
septum to straighten or bow towards the left ventricle in early left ventricular diastole 
[ 51]. The relation between pulmonary artery pressure and septum curvature is further 
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shown in Figure 3.5.28. Higher pulmonary artery pressures are associated with 
septum straightening or bowing into the left ventricle. 
Table 3 .5 .11: Performance of the ventricles in pulmonary hypertension. [78]. 
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Figure 3.5.27: Ventriclar septum curvature in pulmonary hypertension. [78]. 
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3.6 Conclusion 
As was concluded in Section 3.2, the conductance catheter promises to be one of the 
most suitable techniques for an implantable blood flow sensor. Previous research 
identified in Section 3.3 indicated that the effects of catheter position and respiration 
in free breathing, need further investigation. Also, Section 3.5 concluded that since 
volume change in the right ventricle is primarily due to length change, rather than 
change in cross-section area as in the left ventricle, then standard left ventricle 
methods may be grossly inaccurate when applied to finding stroke volumes and 
absolute volumes in the right ventricle. The effects of catheter position and 
myocardium conductivity will be further investigated in the next chapter using 
numerical models. Numerical models provide a controlled experimental 
environment, unparalleled with experimental techniques. 
In the next chapter, models of the heart will be developed from medical imaging 
information to enable simulation of the conductance catheter. The electric field will 
be determined based on finite element analysis. This analysis requires conductivity 
information of various tissues. The geometry will be simplified along with the 
conductivity of tissues. From the detailed information contained in Section 3.4 and 
Section 3.5 (and Section 2.2) the limitations of these models can be put into 
perspective. Little is know about catheter movement during the cardiac cycle. 
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The modelling will be limited to the extent of the myocardium of the ventricles. This 
assumes no current leaks into the relatively low conductivity (Section 3.4) of the 
adjacent liver, lungs and through the fat present around the heart. The model also 
assumes that both the blood and myocardium are isotropic conductors. Blood at low 
shear rates appears to be isotropic (Section 3.4). However, as discussed, myocardium 
conductivity is somewhat anisotropic. The myocardium fibre direction changes 
considerably over a small distance through the ventricle wall as discussed in Section 
3.5. The models assume a normal heart. The effect of pulmonary hypertension on the 
shape and dynamics of the ventricles was discussed in Section 3.5. Myocardium 
motion information allows one to see how the presence of fat can affect the dynamics 
of the ventricles. 
The material on blood flow in Section 3.5 shows how determining blood flow from 
volume changes may lead to error in pulmonary hypertension (due to tricuspid 
regurgitation), but also how other techniques such as ultrasound may be affected by 
the heterogeneous velocity profile. Deformation of the heart due to respiration was 
presented in Section 3.5. The evidence suggests deformation may be modelled in 
future work by applying an affine transformation. 
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Chapter 4. Investigation 1 
4.1 Introduction 
This chapter concentrates on three-dimensional finite element simulation of the 
conductance catheter in the heart. In the last chapter the conductance catheter was 
proposed as one of the most promising techniques for an implantable blood flow 
sensor. Among the most prominent error sources suggested was catheter position. 
Myocardium conductivity may affect both the gain factor and parallel conductance in 
(2.3.1)/(3.2.6). The aim ofthis chapter is to identify the magnitude of effect of these 
two variables. The primary results from the simulation will be five segmental 
voltages at end-diastole and end-systole for an eight-electrode catheter with current 
applied between outer electrodes. The effect of catheter position and myocardium 
conductivity will be assessed for both left and right ventricular catheters. Surfaces of 
the right ventricle, left ventricle and outside of the heart will be modelled based on 
MRI and Tagged MRI images. Each region will be allocated a particular value of 
conductivity. The volumes enclosed by the surfaces will be then meshed into finite 
elements and the electric field for a catheter will be solved. A further aim of this 
chapter is to show it is feasible to develop a realistic three-dimensional model to 
implement the methods detailed in chapters 5 and 6. 
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4.2 Methods 
Two geometry models of the heart were used for the conductance catheter 
simulations. Each was based on a different patient, different imaging technique and 
different reconstruction technique. Two models based on an entirely different 
construction process and different patients somewhat verify each other if the results 
are similar. One of the models was based on MRI images and the other was based on 
Tagged MRI images. A model based on Tagged images was used in addition to one 
based on normal MRI as a lead in to future work, such as modelling fibre orientation 
that would move to a new position as the heart beats. This could be useful for 
modelling heart tissue conductivity that is related to fibre direction. Geometry 
construction related to the MRI model is detailed first under the methods section 
entitled MRI Heart Geometry. Geometry construction related to the Tagged MRI 
model is detailed under the methods section entitled Tagged MRI Heart Geometry. 
The geometry construction process results in volumes representing the heart 
myocardium, left ventricle blood pool and right ventricle blood pool in ANSYS 10.0 
(ANSYS Inc., Canonsburg, USA) with adjoining volumes using the same areas. 
Details of the simulation including incorporation of catheter, conductivity 
assignment, meshing, applying boundary conditions and solving are detailed in the 
methods section entitled Simulation of Conductance Catheter. 
MRI Heart Geometry 
MRI short axis scans through the left and right ventricles of a normal patient were 
obtained from Wendy Strugnell from the Cardiovascular MRI Research Centre at 
The Prince Charles Hospital in Queensland. These images were in the form of 
DICOM format files representing consecutive two-dimensional short axis image 
slices through the patients heart. 
The individual files representing the different slices at end-diastole were imported 
into Amira 4.1.0 (Mercury Computer Systems, Inc., Massachusetts, USA) as an 
image stack. Another image stack was created of the end-systole images (which were 
in the same scanner planes as the end-diastole images). Each image stack was opened 
in Arniras image segmentation editor where points were marked around each of the 
images representing heart myocardium/epicardium border, left ventricle 
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endocardium and right ventricle endocardium. The marked points are shown overlaid 
on the images for end-diastole in Figure 4.2.1 
Figure 4.2.1: MRI short axis images (256 x 256 pixels, viewed from below) at end-
diastole with marked points (coloured) overlaid. Outer ring of points is the outer 
surface of the myocardium. The crescent shaped inner ring of dots on the left of the 
images is the right ventricle endocardium. The circular shaped inner ring on the right 
of the images is the left ventricle endocardium. From apex (upper left image) to base 
(lower right). 
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A three-dimensional array for each image stack with array addresses representing 
pixels of each image stack was then exported from Amira to MATLAB 7.3.0 (The 
MathWorks, Inc., Natick, USA). Assigned to each pixel was a number representing 
the point assigned to it (a different number was assigned to pixels without assigned 
points). A list of points and their array addresses were then generated in MATLAB. 
DICOM header information was then used to convert each array address into 
absolute patient coordinates. The header tags used were image position (0020-0032), 
image orientation (0020-0037) and pixel spacing (0028-0030). The image position 
tag specified the coordinate of the centre of one particular pixel in each two-
dimensional image slice. The other two tags were then used to identify the coordinate 
of every pixel in each two-dimensional image slice. Due to the imaging procedure 
performed the image orientation and pixel spacing tags were the same for every 
image slice. The image position varied between slices with a constant distance 
between slices. 
Cubic B spline curves were fitted to the points representing the outside of the 
myocardium, left ventricle endocardium and right ventricle endocardium in each 
image slice plane. In addition to the points, the only information required to specify 
the splines was the derivatives of the spline segments meeting at each point. The 
derivatives were found by solving a set of simultaneous equations for the derivatives. 
A matrix was formulated for this process. It incorporated desired spline 
boundary/continuity conditions. Cubic B spline curves were then fitted between 
adjacent points on adjacent slices using a similar process. The curve generation 
procedure was written from scratch as available add-ons were not purchased. This 
allowed curve boundary/continuity conditions to be precisely specified to represent 
the geometry best (for instance, cusps were used to represent the septum/right 
ventricular freewall junctions near the apex of the heart and a continuous curve was 
used around the pulmonary artery at the base). 
End point positions and end point derivatives for segments of the fitted splines were 
then used to specify lines in ANSYS finite element software. ANSYS commands 
were then used to fit Coons patches (non-rational B spline or NURBS surfaces) to 
close the wireframe surfaces representing the outside of the myocardium, left 
ventricle endocardium and right ventricular endocardium. These closed surfaces 
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were then converted to volumes. The volumes created from the right ventricle 
endocardium and left ventricle endocardium surfaces represented the two blood 
pools. Boolean operations were used to subtract these two volumes from the volume 
representing the outside of the myocardium. This produced a volume representing 
the myocardium. This volume shared the same areas with the left and right ventricle 
blood pools allowing coupling between the two for later simulation purposes. The 
result of this process was three volumes for end-systole and three volumes for end-
diastole in ANSYS. The three end-diastole volumes in ANSYS are shown in Figure 
4.2.3 
Tagged MRI Heart Geometry 
NURBS surfaces representing the outside of the myocardium of the two ventricles 
and the endocardium of the two ventricles at end-diastole and end-systole were 
obtained from William P. Segars from the Johns Hopkins Outpatient Center in 
Baltimore. These surfaces were generated from Tagged MRI images of a normal 
patient [103]. The four surfaces for each of end-diastole and end-systole were 
continuous with no cusps, each formed out of a single closed NURBS hull. 
The eight surfaces were converted from their custom NURBS geometry description 
into the standard file format IGES using software written from scratch. ANSYS and 
external CAD software was used to convert the two surfaces representing the outside 
of the left and right myocardium into a single surface representing the outside of the 
myocardium. The geometry was too complex for high level ANSYS and external 
CAD commands (they failed) and the combination required use of lowest level 
external CAD commands. The surfaces representing the outside of the myocardium 
and left and right endocardium were converted into volumes in ANSYS. An attempt 
was made to create the myocardium by subtracting the two endocardium/blood pool 
volumes from the outside of myocardium volume using Boolean commands, but this 
failed. Low level commands were used to construct the myocardium volume from 
the same areas as the left and right blood pools (to enable coupling for later 
simulation purposes). The result of this process was three volumes for end-systole 
and three volumes for end-diastole in ANSYS. The three end-diastole volumes in 
ANSYS are shown in Figure 4.2.2. The Tagged MRI end diastole geometry was 
identical in size and wall thickness to the MRI end diastole geometry. 
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Simulation of Conductance Catheter 
The catheter geometry detailed in Figure 4.2.4 was generated in ANSYS in the 
desired location within the desired ventricular blood pool. The catheter volumes 
representing the electrodes and the catheter shaft were then subtracted from the 
surrounding blood pool volume. Desired conductivities were assigned to the various 
volumes. The new blood pool volume, myocardium and other ventricle blood pool 
volume were then meshed to the desired mesh size/distribution using quadratic ten 
node tetrahedral electric solid elements (ANSYS element type: SOLID232). 
Selection of element type was rather arbitrary. A tetrahedral rather than hexahedral 
element was used so that the complex geometry could be meshed efficiently. The 
ANSYS user manual suggested that, in general, quadratic elements (like that used) 
are more efficient than linear elements. After meshing, nodes on the areas 
representing the catheter electrodes were coupled in the VOLT degree of freedom. A 
source current of 1 AMP was applied to one of the end electrodes of the catheter and 
a voltage of zero was applied to the electrode on the other end. The solution for 
electric potential, based on the governing equation: 
Y'·(kvu)=O, 
where: k = conductivity tensor, u = potential, 
4.2.1 
was solved by formulating a matrix for the node voltages and solving using the 
ANSYS sparse matrix solver. The voltage differences across the five segments 
between the middle six electrodes of the catheter were calculated by subtracting 
electrode node voltages and recorded. 
Two types of studies were performed. In the first, the catheter was moved and 
conductivity remained constant. In the second, the catheter was fixed and 
conductivity ratios were varied. The models were solved for the variety of catheter 
positions and blood/myocardium conductivity ratios detailed in Table 4.2.1. The 
procedure was fully automated by parameterising the catheter position and 
conductivity ratio. A blood/myocardium conductivity ratio of 2.75 was used for 
catheter position studies and comparison of the MRI and Tagged MRI based models. 
The catheter was moved between five positions in two planes, approximately 
perpendicular to each other. The maximum movement range was between 1 Omm and 
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20mm at the base (15mm left ventricle, lOmm right ventricle in septum-free wall 
direction, and 20mm right ventricle in pulmonary artery-liver direction). This was the 
practical range of movement for a straight catheter, without penetrating the 
myocardium. The range was approximately centred in the ventricles. In the second 
type of study the blood/myocardium conductivity ratio was varied between 1 and 4.5. 
This range represents possible blood/myocardium conductivity ratio. 
Table 4.2.1: Different studies (end diastole and end systole). PA-L: pulmonary artery 
to liver direction, FW-S: ventricle free wall to ventricle septum direction. 
Investigation Ventricle Model O"blood/ O"tissue Catheter Position 
A Left TaggedMRI 2.75 centre 
B Right Tagged MRI 2.75 centre 
c Left MRI 2.75 centre 
D Right MRI 2.75 centre 
E Left TaggedMRI 2.75 4 positions PA-L 
F Left TaggedMRI 2.75 4 positions FW-S 
G Right TaggedMRI 2.75 4 positions PA-L 
H Right TaggedMRI 2.75 4 positions S-FW 
I Left TaggedMRI 1, 1.875, 3.625, 4.5 centre 
J Right TaggedMRI 1, 1.875, 3.625, 4.5 centre 
From the segment voltages four different values were calculated. These were: 
. Ves-Vesc 1. Percentage change m Ves = 100 , 
Vesc 
(4.2.2) 
where: Ves = segment voltage for end-systole, Vesc = segment voltage for end-
systole of either investigation A or B. 
2. (Ves - Ved) I Ves, 
where: Ved = segment voltage for end-diastole. 
. (Ves - Ved )- (Vesc - Vedc) 3. Percentage change m (Ves- Ved) = 100 , 
Vesc-Vedc -
where: Vedc = segment voltage for end-diastole of either investigation A or B. 
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(4.2.3) 
(4.2.4) 
Ves - Ved Vesc - Vedc 
4. Percentage change in (Ves - Ved) I Ves = lOO--Vi_es_Vi-es_c __ -Vi-ed_~_es_c_ 
Vesc 
(4.2.5) 
Equation ( 4.2.2) is the change in actual voltage, as a percent, due to a change in 
variables. The end systolic voltage will in general have a greater percent change than 
the end diastole voltage. 
Equation ( 4.2.3) is the percent of the end systole voltage minus end diastole voltage 
relative to the end systole voltage. Comparison of ( 4.2.2) with ( 4.2.3) gives an idea 
of the error in stroke volume (using the standard conductance catheter technique) due 
to a change in variables that only occurs during one part of the cardiac cycle. For 
instance rapid variable changes like a change in catheter position. Similar magnitude 
of (4.2.3) and (4.2.2) indicate 100% error. 
Equation (4.2.4) is the percentage change in end systole voltage minus end diastole 
voltage, as a percent, due to a change in variables. Equation (4.2.4) gives an idea of 
the error in stroke volume (using the standard conductance catheter technique) due to 
a change in variables that remains through the whole cardiac cycle. For instance slow 
variable changes like a normal change in blood/tissue conductivity. A value of 1 % 
would indicate 1 % error. 
Equation (4.2.5) is the percentage change in (4.2.3) due to a change in variables. 
Equation (4.2.5) gives an idea of whether a change in end systole voltage minus end 
diastole voltage can be cancelled out by the change in end systole voltage. For small 
values of ( 4.2.3), ( 4.2.5) also gives an idea of whether a change in end systole 
voltage minus end diastole voltage can be cancelled out by the change in end diastole 
voltage. 
Note that the stroke volume calculated using the standard conductance catheter 
technique is based on the inverse of the absolute voltages (the conductances). 
However subtraction of two voltages (divided by a voltage) will give the same 
magnitude as subtraction of the corresponding two conductances (divided by a 
conductance) provided the difference is small. This is further discussed in Section 
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4.4. Voltages were used instead of conductances in calculation of ( 4.2.2), ( 4.2.3), 
(4.2.4) and (4.2.5) to be consistent with inverse mapping inputs in Chapter 5 and 
Chapter 6. However, for a paper that was primarily assessing error in the standard 
conductance catheter technique, use of conductances would be more appropriate than 
voltages. This would give exact error rather than approximate error. 
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Figure 4.2.2 : Tagged MRI based end diastole geometry. From left: view from base of 
heart myocardium, heart myocardium, left and right ventricles. 
Figure 4.2.3: MRI based end diastole geometry. From left: view from base of heart 
myocardium, heart myocardium, left ventricle and right ventricle. 
Figure 4.2.4: Simulated eight electrode catheter. Electrode spacing= 7mm, electrode 
width = 1 mm, total length of catheter = 62mm, diameter of catheter = 2.4mm. 
82 
4.3 Results 
Investigation A, B, C and D are compared in Figures 4.3.1 and Figure 4.3.2. These 
figures show the absolute segment voltages for a catheter in a central position in the 
left and right ventricles respectively for both the MRI and Tagged MRI geometry. 
Note: the similarity between tagged MRI and MRI model; the increase in segment 
voltages towards the source electrodes; the smaller difference between end systole 
and end diastole voltages in the right ventricle, relative to the left ventricle. The 
remainder of the results presented pertain to tagged MRI geometry only. 
Investigation A contour plots are given in Figures 4.3.3 and 4.3.4. These figures 
show contour plots of voltage potential (with a constant voltage difference between 
the contours) at end-systole and end-diastole respectively for a catheter in the centre 
of the left ventricle. Note: the similarity between the end systole and end diastole 
figures; that the contours are perpendicular to the external surfaces of the model. 
Lines perpendicular to the contours indicate current flow direction. Closely spaced 
contours indicate relatively high potential gradient and high current density (or low 
conductivity). Contours indicate most current flow is through the left ventricle. 
Investigation B contour plots are given in Figures 4.3.5 and 4.3.6. These figures are 
equivalent but for a catheter in the centre of the right ventricle. Contours for the right 
ventricle catheter indicate relatively more current flow through the opposite 
ventricle. 
Investigation E and F contour plots are shown in Figures 4.3.7 to 4.3.10. These 
figures show contour plots for catheters off centre in two approximately orthogonal 
planes in the left ventricle. Only the catheter positions furthest from the centre are 
shown. Note: the range of the offset catheters and their position relative to the 
myocardium in the end systole and end diastole cross sections; the 
blood/myocardium border marked on the top surface of the heart and its continuation 
through the cross sections defined by a slight abrupt change in direction of the 
contours. Investigation E, F and A segment voltages were transformed into the four 
values detailed in Section 4.2. The values for each segment in all five positions in the 
two planes of catheter movement are shown in Figures 4.3 .11 to 4.3 .14. Each figure 
presents one of the four values calculated from end-diastole and end-systole segment 
83 
voltages. Note: the minimum percentage change in Ves is towards the centre in 
Figure 4.3.11; the relative magnitude between percentage change in Ves in Figure 
4.3.11 and (Ves - Ved)Nes in Figure 4.3.12; that the minimum percentage change in 
(Ves - Ved) is towards the centre in Figure 4.3.13; that the minimum percentage 
change in (V es - Ved)N es is towards the centre in Figure 4.3 .14. 
Investigation G and H contour plots are shown in Figures 4.3.15 to 4.3.18. These 
figures show contour plots for catheters off centre in two approximately orthogonal 
planes in the right ventricle. Only the catheter positions furthest from the centre are 
shown. Investigation G, H and B segment voltages were transformed into the four 
values detailed in Section 4.2. The values for each segment in all five positions in the 
two planes of catheter movement are shown in Figures 4.3.19 to 4.3.22. Each figure 
presents one of the four values calculated from end-diastole and end-systole segment 
voltages. Note similar features in these figures as Figures 4.3.11to4.3.14. 
Investigation I contour plots are shown in Figures 4.3.23 and 4.3.24. These figures 
show contour plots for a centralised catheter in the left ventricle with different 
blood/myocardium conductivity ratios. Contours are shown for voltages in the 
middle third of the voltage between source electrodes. Note: the abrupt change in 
contour direction at the blood/myocardium borders in the lower figures representing 
a ratio of 4.5 and no change in contour direction in the top figures, representing a 
ratio of 1; the flatter contours in the lower figures indicating less current flow into the 
right ventricle. Investigation I and A segment voltages were transformed into the four 
values detailed in Section 4.2. The values for each segment for all five 
blood/myocardium conductivity ratios are plotted in Figures 4.3.25 to 4.3.28. Each 
figure presents one of the four values calculated from end-diastole and end-systole 
segment voltages. Note: the moderate increase in percentage change in Ves with ratio 
in Figure 4.3.25; the change is minimum for segments closest to the source 
electrodes; (Ves - Ved)/Ves increases and converges with increasing ratio in Figure 
4.3.26; lower values for the segments closest to the source electrodes; the strong 
increase in percentage change in (Ves - Ved) with ratio in Figure 4.3.27; that change 
is minimum for segments closest to the base; that the percentage change in (V es -
Ved)Nes with ratio in Figure 4.3.28 is similar to the percentage change in (Ves -
Ved) with ratio in Figure 4.3.27. 
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Investigation J contour plots are shown in Figures 4.3.29 and 4.3.30. These figures 
show contour plots for a centralised catheter in the right ventricle with different 
blood/myocardium conductivity ratios. Contours are shown for voltages in the 
middle third of the voltage between source electrodes. Investigation J and B segment 
voltages were transformed into the four values detailed in Section 4.2. The values for 
each segment for all five blood/myocardium conductivity ratios are plotted in Figures 
4.3.31 to 4.3.34. Each figure presents one of the four values calculated from end-
diastole and end-systole segment voltages. Note similar features in these figures as 
Figures 4.3.25 to 4.3.28. 
The different results presented are summarised in Table 4.3.1. Data generated from 
models with typically 250,000 to 275,000 degrees of freedom (nodes). Studies of 
convergence by increased refinement of mesh indicated error on the order of 0.1 % or 
less. 
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Table 4.3 .1: Results Summary. 
Figure Investigation( s) Description (from Table 4.2. l) 
4.3.1 A,C Segment voltages: bar plot ofVes and Ved 
4.3.2 B,D Segment voltages: bar plot ofVes and Ved 
4.3.3 A Distributed voltage contour plots (end systole) 
4.3.4 A Distributed voltage contour plots (end diastole) 
4.3.5 B Distributed voltage contour plots (end systole) 
4.3.6 B Distributed voltage contour plots (end diastole) 
4.3.7 E Distributed voltage contour plots (end systole) 
4.3.8 E Distributed voltage contour plots (end diastole) 
4.3.9 F Distributed voltage contour plots (end systole) 
4.3.10 F Distributed voltage contour plots (end diastole) 
4.3.11 E,F,A Segment voltages:% change in Ves 
4.3.12 E,F,A Segment voltages: (Ves - Ved) I Ves 
4.3.13 E,F,A Segment voltages: % change in (Ves - Ved) 
4.3.14 E,F,A Segment voltages: % change in (V es - Ved) I Ves 
4.3.15 G Distributed voltage contour plots (end systole) 
4.3.16 G Distributed voltage contour plots (end diastole) 
4.3.17 H Distributed voltage contour plots (end systole) 
4.3.18 H Distributed voltage contour plots (end diastole) 
4.3.19 G,H,B Segment voltages: % change in Ves 
4.3.20 G,H,B Segment voltages: (Ves - Ved) I Ves 
4.3.21 G,H,B Segment voltages:% change in (Ves- Ved) 
4.3.22 G,H,B Segment voltages: % change in (Ves - Ved) I Ves 
4.3.23 I Distributed voltage contour plots (end systole) 
4.3.24 I Distributed voltage contour plots (end diastole) 
4.3.25 I,A Segment voltages: % change in Ves 
4.3.26 I,A Segment voltages: (Ves - Ved) I Ves 
4.3.27 I,A Segment voltages: % change in (Ves - Ved) 
4.3.28 I,A Segment voltages: % change in (Ves - Ved) I Ves 
4.3.29 J Distributed voltage contour plots (end systole) 
4.3.30 J Distributed voltage contour plots (end diastole) 
4.3.31 J, B Segment voltages:% change in Ves 
4.3.32 J,B Segment voltages: (Ves - Ved) I Ves 
4.3.33 J,B Segment voltages: % change in (Ves - Ved) 
4.3.34 J,B Segment voltages: % change in (Ves - Ved) I Ves 
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Figure 4.3.1: Absolute segment voltages in tagged MRI model (black) and MRI 
model (white) for catheter in left ventricle. Larger voltages are end systole, smaller 
voltages are end diastole. See Figure 4.3.3 and Figure 4.3.4 for position of catheter. 
Blood conductivity/myocardium conductivity= 2.75. 
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Figure 4.3.2: Absolute segment voltages in tagged MRI model (black) and MRI 
model (white) for catheter in right ventricle. Larger voltages are end systole, smaller 
voltages are end diastole. See Figure 4.3.5 and Figure 4.3.6 for position of catheter. 
Blood conductivity/myocardium conductivity= 2.75. 
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Figure 4.3 .3: Left ventricle catheter voltage contours in tagged MRI model at end 
systole for blood conductivity/myocardium conductivity = 2.75 . 
88 
Figure 4.3.4: Left ventricle catheter voltage contours in tagged MRI model at end 
diastole for blood conductivity/myocardium conductivity= 2.75. 
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Figure 4.3.5: Right ventricle catheter voltage contours in tagged MRI model at end 
systole for blood conductivity/myocardium conductivity= 2.75. 
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Figure 4.3.6: Right ventricle catheter voltage contours in tagged MRI model at end 
diastole for blood conductivity/myocardium conductivity= 2.75. 
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Figure 4.3 .7: Off centre (pulmonary artery - liver direction) left ventricle catheter 
voltage contours m tagged MRI model at end systole for blood 
conductivity/myocardium conductivity = 2. 75. 
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Figure 4.3 .8: Off centre (pulmonary artery - liver direction) left ventricle catheter 
voltage contours m tagged MRI model at end diastole for blood 
conductivity/myocardium conductivity= 2.75. 
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Figure 4.3.9: Off centre (septum - free wall direction) left ventricle catheter voltage 
contours in tagged MRI model at end systole for blood conductivity/myocardium 
conductivity= 2. 75 . 
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Figure 4.3 .10: Off centre (septum - free wall direction) left ventricle catheter voltage 
contours in tagged MRI model at end diastole for blood conductivity/myocardium 
conductivity = 2.75. 
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Figure 4.3 .11: Percentage change in segment end systole voltage (V es) for off centre 
left ventricle catheter in tagged MRI model for blood conductivity I myocardium 
conductivity= 2.75. Lines represent catheter axes. Centre of numbers are positioned 
at centre of segments. Origin of coordinate system is catheter rotation point. 
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Figure 4.3.12: Percentage absolute segment (Ves - Ved ) I Ves for off centre left 
ventricle catheter in tagged MRI model for blood conductivity I myocardium 
conductivity= 2.75. Lines represent catheter axes. Centre of numbers are positioned 
at centre of segments. Origin of coordinate system is catheter rotation point. 
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Figure 4.3 .13: Percentage change in segment (Ves - Ved ) for off centre left ventricle 
catheter in tagged MRI model for blood conductivity I myocardium conductivity = 
2.75. Lines represent catheter axes. Centre of numbers are positioned at centre of 
segments. Origin of coordinate system is catheter rotation point. 
98 
-10 -5 0 5 10 
pulmonary artery (mm) liver 
-10 -5 0 5 10 
free wall (mm) septum 
Figure 4.3.14: Percentage change in segment (Ves - Ved) I Ves for off centre left 
ventricle catheter in tagged MRI model for blood conductivity I myocardium 
conductivity= 2.75. Lines represent catheter axes. Centre of numbers are positioned 
at centre of segments. Origin of coordinate system is catheter rotation point. 
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Figure 4.3 .15: Off centre (liver - pulmonary artery direction) right ventricle catheter 
voltage contours m tagged MRI model at end systole for blood 
conductivity/myocardium conductivity= 2.75. 
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Figure 4.3.16: Off centre (liver - pulmonary artery direction) right ventricle catheter 
voltage contours m tagged MRI model at end diastole for blood 
conductivity/myocardium conductivity= 2.75. 
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Figure 4.3.17: Off centre (septum - free wall direction) right ventricle catheter 
voltage contours m tagged MRI model at end systole for blood 
conductivity/myocardium conductivity= 2.75. 
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Figure 4.3.18: Off centre (septum - free wall direction) right ventricle catheter 
voltage contours m tagged MRI model at end diastole for blood 
conductivity/myocardium conductivity= 2.75. 
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Figure 4.3.19: Percentage change in segment end systole voltage (Ves) for off centre 
right ventricle catheter in tagged MRI model for blood conductivity I myocardium 
conductivity= 2.75. Lines represent catheter axes. Centre of numbers are positioned 
at centre of segments. Origin of coordinate system is catheter rotation point. 
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Figure 4.3.20: Percentage absolute segment (Ves - Ved) I Ves for off centre right 
ventricle catheter in tagged MRI model for blood conductivity I myocardium 
conductivity= 2.75. Lines represent catheter axes. Centre of numbers are positioned 
at centre of segments. Origin of coordinate system is catheter rotation point. 
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Figure 4.3.21: Percentage change in segment (Ves - Ved ) for off centre right 
ventricle catheter in tagged MRI model for blood conductivity I myocardium 
conductivity= 2.75. Lines represent catheter axes. Centre of numbers are positioned 
at centre of segments. Origin of coordinate system is catheter rotation point. 
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Figure 4.3.22: Percentage change in segment (Ves - Ved) I Ves for off centre right 
ventricle catheter in tagged MRI model for blood conductivity I myocardium 
conductivity= 2.75. Lines represent catheter axes. Centre of numbers are positioned 
at centre of segments. Origin of coordinate system is catheter rotation point. 
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Figure 4.3.23: Left ventricle catheter voltage contours in tagged MRI model at end 
systole. Top: blood conductivity/myocardium conductivity = 1.0. Bottom: blood 
conductivity/myocardium conductivity= 4.5. 
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Figure 4.3 .24: Left ventricle catheter voltage contours in tagged MRI model at end 
diastole. Top: blood conductivity/myocardium conductivity = 1.0. Bottom: blood 
conductivity/myocardium conductivity= 4.5. 
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Figure 4.3.25: Percentage change in segment end systole voltage (Ves) for left 
ventricle catheter in tagged MRI model. 
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Figure 4.3.26: Percentage absolute segment (Ves - Ved ) I Ves for left ventricle 
catheter in tagged MRI model. 
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Figure 4.3.27: Percentage change in segment (Ves - Ved) for left ventricle catheter 
in tagged MRI model. 
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Figure 4.3.28: Percentage change in segment (Ves - Ved ) I Ves for left ventricle 
catheter in tagged MRI model. 
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Figure 4.3.29: Right ventricle catheter voltage contours in tagged MRI model at end 
systole. Top: blood conductivity/myocardium conductivity = 1.0. Bottom: blood 
conductivity/myocardium conductivity= 4.5. 
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Figure 4.3.30: Right ventricle catheter voltage contours in tagged MRI model at end 
diastole. Top: blood conductivity/myocardium conductivity = 1.0. Bottom: blood 
conductivity/myocardium conductivity= 4.5 . 
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Figure 4.3 .31: Percentage change in segment end systole voltage (Ves) for right 
ventricle catheter in tagged MRI model. 
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Figure 4.3.32: Percentage absolute segment (Ves - Ved) I Ves for right ventricle 
catheter in tagged MRI model. 
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Figure 4.3.33: Percentage change in segment (Ves - Ved) for right ventricle catheter 
in tagged MRI model. 
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Figure 4.3.34: Percentage change in segment (Ves - Ved) I Ves for right ventricle 
catheter in tagged MRI model. 
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4.4 Discussion 
The MRI model and tagged MRI model showed good agreement. The MRI end-
diastole segment voltages, in Figure 4.3.1 and 4.3.2, were within 7% of tagged MRI. 
The MRI end-systole segment voltages were within 8% of tagged MRI, except at the 
apex. The MRI end-diastole to end-systole segment voltage differences were within, 
23% in the left ventricle and 36% in the right ventricle, of tagged MRI, except at the 
apex. 
In both the left and right ventricles an offset catheter generally causes an increase in 
end-systole segment voltage (Ves), and increase in (Ves - Ved). In general, this 
means worst case error results from catheter movement between centre and closer to 
the myocardium. The small negative values are due to the fact that what these 
investigations defined as centralised catheter were not quite the same centralised 
catheter position that is defined by minimum segment voltages. This new catheter 
centre definition is closer to the pulmonary artery and septum for the right ventricle 
catheter. For the left ventricle catheter it is closer to the septum, closer to the 
pulmonary artery at the apex and closer to the liver at the base. (Ves - Ved) is almost 
directly used to determine stroke volume using the standard conductance catheter 
formula. Using the standard conductance catheter formula, stroke volume is 
proportional to segment (1Ned-1Nes). Assuming Ves- Ved << Ves or Ved, and a 
small error, a one percentage error in (Ves - Ved) for all segments (middle segments 
are more heavily weighted) will have approximately a one percent opposite effect on 
predicted stroke volume. So an increase in (Ves - Ved) from movement off centre 
will underestimate volume. The increase in (Ves - Ved) is typically greater than the 
increase in Ves, as indicated by percentage change in segment (V es - Ved)N es 
plots. This means that the increase is not proportional to Ves and Ved, and that Ves 
increases proportionally more than Ved. It may be possible for the catheter to move 
during a cardiac cycle. If it moves off centre during systole only, the change in Ves 
will cause a change in (Ves - V ed) that may be greater than the change in (V es -
Ved) for a catheter off centre during the whole of the cardiac cycle. In the left 
ventricle the change in Ves is on the order of about 10% of (V es - Ved)N es. In 
contrast the change in (V es - Ved) is also on the order of 10% for the catheter 
movement shown. In the right ventricle the change in Ves is on the order of 25% to 
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50% of (Ves - Ved)N es. In contrast the change in (Ves - Ved) is on the order of 5% 
to 10% but a massive 25% with the catheter towards the liver. A right ventricle 
catheter moving off-centre during just systole may give a large error, but a catheter 
that is off centre but stationary throughout the cardiac cycle may give less error 
(except near the liver), due to some cancellation. 
The order of magnitude of the results suggest that error due to catheter movement is 
significant in both the left and right ventricles. This is especially true since the 
catheter movements investigated were not the maximum possible. A curved catheter 
may also give even more error, but is more likely to decrease the segment voltages 
since the catheter may be at an angle relative to the contours between source 
electrodes. 
The absolute segment (Ves - Ved)Nes value for a conductivity ratio of 2.75 gives 
similar results to left and right ventricle experimental studies in the literature. The 
slopes of the segment curves decrease in magnitude and converge with increasing 
ratio. The values of the (Ves - Ved)N es curves are all quite low at ratios near 1 
signifying increased conductivity of the opposite ventricle and myocardium. 
Maximum values are indicated for the middle segments due to local field effects 
creating higher voltage near the electrodes. This is further supported by a higher 
change in Ves for the middle segments compared to the apex and particularly in the 
right ventricle the base segments. The change in percentage (V es - V ed) is strong 
and shows a clear pattern. For both ventricles the apex segment changes the most and 
the base segment the least, with gradual transition. In this regard the base segments, 
while they are less sensitive (lower Ves-VedNes ratio) to the motion of the heart, 
they give less error at predicting motion with a change in ratio. The (V es - Ved) is 
affected much more by changes in ratio than V es, resulting in a similar pattern for 
percentage change in (V es - Ved)N es. This means that the increase is not 
proportional to Ves and Ved, and that V es increases proportionally more than V ed. 
Higher ratio causes an over estimation in volume and lower ratio causes an 
underestimation of volume. CJJ.anges in ratio, for instance, down to 2 or up to 4, 
cause changes in (Ves - Ved) on the order of 25% for both ventricles. This sort of 
order of error makes the effect ofratio changes highly significant in both ventricles. 
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The modelling in this chapter has a number of limitations. These can be identified 
based on information compiled in the literature review chapter. This model assumed 
no current passed beyond the myocardium into surrounding tissues. This was based 
on the assumption that the heart is either covered with insulating adipose tissue (fat) 
or surrounded by insulating lung tissue. The surface of the heart in contact with the 
diaphragm/liver has little fat and some current may leak into the relatively low 
conductivity liver despite a large amount of fat covering the heart. 
A more minor assumption was that the effects of anisotropic tissue conductivity 
could be ignored. Since the muscle fibre direction is in all directions in the plane of 
the myocardium, an equivalent isotropic value that has the same effect was assumed. 
Also another assumption is that trabeculations can be modelled as some smooth 
boundary between blood and myocardium. 
Another limitation of this work is that it only tests one particular catheter geometry. 
A longer catheter may give less (most likely) error. To simulate a longer catheter 
however it may be necessary to extend the model into the atria, aorta and pulmonary 
artery, so source electrodes can be positioned outside the ventricle. Also the catheter 
was positioned as a straight catheter between base and apex. This minimised the 
effect of current flow into the base regions of the heart as the base was behind one of 
the source electrodes in the source electrode to source electrode direction. Accurate 
modelling of a catheter, for instance, between tricuspid valve and pulmonary artery 
would require inclusion of the atria and pulmonary artery, since the fibrous ring 
forming the base of the heart only acts as an insulator to active current propagation 
(depolarisation wave), not passive current flow. In such a situation anywhere up to 
half of the current may flow through the base region. The current flow only depends 
on source electrode positions, it has nothing to do with measurement electrode 
positions. Even if the measurement electrodes are curved towards the apex in such a 
situation, one must not neglect current flow through the base (to get an accurate 
result). 
This study only investigated the effect on catheter measurements under the same 
conditions so calculation of ventricle volume was not required. Whatever the catheter 
position used, to obtain accurate ventricle volume from the model one would have to 
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model the full ventricles up to the level of the pulmonary, tricuspid, aortic and mitral 
valves. One cannot simply slice off the model near the valves since the valve plane 
moves during the cardiac cycle. Doing so, especially in the right ventricle would lead 
to inaccurate stroke volume changes as well as average volume. Conditions such as 
tricuspid regurgitation could make it impossible to determine blood flow from stroke 
volume if this was desired. This chapter also only considered normal human heart 
geometry. Hypertrophied and different sized hearts from humans may give different 
results. Animal hearts may also give different results. 
4.5 Conclusion 
The main conclusion from the work in this chapter is that catheter movement and 
changes in blood conductivity/myocardium conductivity may give significant error in 
the standard conductance catheter technique. In the next chapter the problem of 
correcting for these variables and others will be addressed in a simplified model of 
the heart. 
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Chapter 5. Investigation 2 
5.1 Introduction 
The purpose of this chapter is to investigate how well noiseless catheter 
measurements can be used to determine ventricular volume, tissue impedance and 
catheter position in a simple two-dimensional model. The previous chapter showed 
that catheter movement and tissue impedance changes give non-negligible error 
using existing methods for calculating folume from impedance measurements. 
Correction of these error sources is attempted by using additional information from 
different current source configurations and frequency changes in tissue properties. 
Different source configurations and source frequencies represent the only two source 
variables that can be changed. The ability to correct for the error sources using these 
variables is examined in a simplified model of the heart. The model will simulate 
simultaneous, four electrode technique catheter measurements taken at two different 
:frequencies and multiple current source electrode separations. Finite element 
modelling offers the possibility of incorporating a priori information about geometry 
and electrical properties to map electrode measurements to stroke volume or blood 
flow. The effect of high frequency will be simulated by an exact 1.35 increase in 
tissue conductivity and a zero change in blood conductivity. Due to the simple, low 
variable number model used in this section only a subset of possible source current 
and voltage measurement configurations will be employed. First the derivatives of 
these voltage measurements will be calculated with respect to model variables to 
examine the magnitude of effect on catheter measurements. These derivative vectors 
will be compared to establish the separability of the effects of the three parameters. 
The technique employed to do this gives great insight into the mapping. Finally two 
different techniques will be employed to obtain an inverse mapping to the numerical 
model. These techniques will attempt to map catheter measurements to numerical 
model parameters. The two inverse techniques comprise neural networks and a new 
technique. It will be shown that a custom inverse mapping method outperforms the 
best conventional technique. 
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5.2 Methods 
The parameterised two-dimensional numerical model used for studies in this chapter 
is detailed in the section entitled Numerical Model. Methods to calculate and 
compare the derivatives of catheter measurements with respect to the parameters of 
the numerical model are detailed in the section entitled Local Derivatives of the 
Numerical Model. Inverse mapping using neural networks of catheter measurements 
to model parameters is detailed in the section entitled Inverse Mapping Using Neural 
Networks. Finally inverse mapping using a new technique is detailed in the section 
Inverse Mapping Using New Distance Function Technique. 
Numerical Model 
The work in this chapter is based on the two-dimensional numerical model geometry 
shown in Figure 5.2.1. The model is parameterised by the variables r, p, and c, 
where: r represents half the width of the blood pool, p represents the distance the 
catheter is offset towards the tissue wall from the centre of the blood pool, and c 
represents the blood conductivity/myocardium conductivity ratio. The numerical 
model produces the voltage= voltage (V) x blood conductivity (S/m) I current (A) x 
width of model (m). This is the definition of all absolute voltages given in the results. 
The model has 10 electrodes. Distance between electrodes is 8mm and electrode 
length is lmm. 
r 
_L c 
_L 
1 2 3 4 5 6 7 8 9 10 
- - - - - - - -
-
- 1 
p 
10.00 cm 
Figure 5.2.1: Numerical Model Geometry (drawn to scale). Model parameters: r = 
l.75cm, p/r = 0.4. 
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All numerical modelling in this chapter is implemented using ANSYS finite element 
software version 10.0. The geometry is meshed in ANSYS using 2D eight node 
electric area elements (ANSYS element type: PLANE230). Element nodes along the 
electrodes are coupled in the VOLT degree of freedom to model each electrode. The 
solution for electric potential, based on the governing equation 
\7 · (k\lu) = 0, 
where: k = conductivity tensor, u =potential, 
(5.2.1) 
is solved (after application of boundary conditions) by formulating a matrix for the 
node voltages and solving using the ANSYS sparse matrix solver. 
To obtain one set of catheter voltage measurements for a particular combination of r, 
p, and c, the numerical model is run four times, corresponding to four alternative 
"current" electrode pairs. The pairs used were electrodes 4-7, 3-8, 2-9 and 1-10. A 
voltage was set on one electrode, and a current on the other. Resulting voltages were 
measured between points of adjacent electrodes spanned by the "current" electrodes. 
Due to symmetry some of these voltages were the same and redundant voltages were 
not measured. These combinations of boundary conditions and measured voltages are 
shown in Table 5.2.1, as detailed below. 
The first time the model is run with a source current of 1 AMPS at electrode 7 and 
voltage of zero at electrode 4. The voltage at electrode 6 minus the voltage at 
electrode 5 is recorded as the first catheter measurement. The second time the model 
is run with a source current of 1 AMPS at electrode 8 and voltage of zero at electrode 
3. The voltage at electrode 6 minus the voltage at electrode 5 is recorded as the 
second catheter measurement. The voltage at electrode 7 minus the voltage at 
electrode 6 is recorded as the third catheter measurement. The third time the model is 
run with a source current of 1 AMPS at electrode 9 and voltage of zero at electrode 
2. The voltage at electrode 6 minus the voltage at electrode 5 is recorded as the 
fourth catheter measurement. The voltage at electrode 7 minus the voltage at 
electrode 6 is recorded as the fifth catheter measurement. The voltage at electrode 8 
minus the voltage at electrode 7 is recorded as the sixth catheter measurement. The 
fourth time the model is run with a source current of 1 AMPS at electrode 10 and 
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voltage of zero at electrode I. The voltage at electrode 6 minus the voltage at 
electrode 5 is recorded as the seventh catheter measurement. The voltage at electrode 
7 minus the voltage at electrode 6 is recorded as the eighth catheter measurement. 
The voltage at electrode 8 minus the voltage at electrode 7 is recorded as the ninth 
catheter measurement. The voltage at electrode 9 minus the voltage at electrode 2 is 
recorded as the tenth catheter measurement. 
Table 5.2. I: Measured voltages from numerical model 
Measurement Current electrodes Measured voltage (electrodes) 
Vi 4 (OV), 7 (lA) 6minus 5 
V2 3 (OV), 8 (IA) 6minus 5 
Vi 3 (OV), 8 (IA) ?minus 6 
Vi 2 (OV), 9 (IA) 6 minus 5 
Vi 2 (OV), 9 (IA) 7 minus 6 
Vi 2 (OV), 9 (IA) 8 minus 7 
Vi 1 (OV), 10 (lA) 6 minus 5 
Vs 1 (OV), 10 (lA) ?minus 6 
Vi 1 (OV), 10 (IA) 8 minus 7 
Vio 1 (OV), 10 (lA) 9 minus 8 
A total of twenty catheter measurements were obtained by running the model at both 
low frequency and high frequency. The high frequency catheter measurements 
eleven to twenty were obtained exactly the same way as catheter measurements one 
to ten except the tissue conductivity was multiplied by I.35. 
The convergence of the numerical model was assessed by changing the primary 
mesh density of the model. At different mesh densities the catheter measurements, 
number of nodes (degrees of freedom) and element count were recorded. A fixed set 
of model parameters (r = 1.75cm, p/r = 0.4, c = 2.75), representing average values 
used in this chapter, were used for assessing convergence. Using these same model 
parameters a total of eight different primary (the mesh was further refined around the 
electrodes) mesh densities were simulated. These primary mesh densities were: 
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0.0400, 0.0433, 0.0531, 0.0694, 0.0922, 0.1216, 0.1576, 0.2000 (cm). Results are 
shown in Section 5.3. 
Local Derivatives of the Numerical Model 
Local derivatives for a total of 20 catheter measurements were calculated using finite 
differencing of numerical model results. The local derivatives were calculated at only 
one set of the three parameters. The values of the three parameters are the same as 
that used for convergence assessment and represent approximately average values 
used in this chapter. 
Partial derivatives with respect to r were calculated by generating 20 catheter 
measurements at the position r = 1.76 and r = 1.74 and given by: 
oV, (r = 1.75,p I r = 0.4, c = 2.75) = V, (r = 1.76, p I r = 0.4,c = 2.75)-V, (r = 1.74,p I r = 0.4, c = 2.75) 
or 0.02 
where: ~ = catheter measurement i. 
Partial derivatives with respect to p/r were calculated by generating 20 catheter 
measurements at the position p/r = 0.41 and p/r = 0.39 and given by: 
av, (r =l.75,p/ r = 0.4,c = 2.75) = v, (r =l.75,p/ r = 0.41,c = 2.75)-V,(r =l.75,p/r = 0.39,c = 2.75) 
8p/r 0.02 
where: Vi= catheter measurement i. 
Partial derivatives with respect to c were calculated by generating 20 catheter 
measurements at the position c = 2.76 and c = 2.74 and given by: 
av, (r =l.75,p/r = 0.4,c = 2.75) V,(r =l.75,p/r =0.4,c = 2.76)-V,(r =l.75,p/ r = 0.4,c = 2.74) 
ac 0.02 
where: Vi= catheter measurement i. 
The partial derivatives were organised into three vectors: 
av -[av; av2 av, av20 J dr- Br & ar ··· & ' 
~ -[ av; av2 av, av20 J 
dp/r - 8plr 8p/r 8p/r ··· 8p/r ' 
av =[av; av2 
de ac ac 
8V, 8V20 ] 
ac ... Tc. 
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Angles in Euclidean space were generated between full and subsets of these three 
(one for each of r, p/r and c) partial derivative vectors to give some insight into how 
well conditioned the inverse mapping is locally and the most important catheter 
measurements. 
Inverse Mapping Using Neural networks 
Neural networks were created using the MATLAB functions newff() and newgrnn() 
with the training data. Newff() was used to create simple feedforward networks and 
newgrnn() was used to create radial basis networks. Various feedforward networks 
were created with different numbers of hidden layers (1 or 2) and hidden layer 
neurons (3-20). The hidden layers all used the transfer function 'tansig' and had an 
output layer transfer function 'purelin'. Various radial basis networks were created 
with different values of spread constant (the Euclidean distance of the test data points 
from the training data points at which the radial basis functions outputs are half their 
maximum). All networks were configured to give a single output variable r with the 
20 catheter measurements as inputs. After training the networks were applied with 
the test data to give a prediction for r. The actual value of r parameter from the test 
data was then subtracted from the r value given by the network to give the error. 
Generation of training data was done in a 8x8x8 evenly spaced grid of model 
parameters. A set of 10 low frequency catheter measurements were recorded (by 
running the numerical model with a primary mesh density of 0.2cm) for each of the 
512 grid points representing all combinations of the three model parameters: 
r (cm)= [1, 1.214, 1.429, 1.643, 1.857, 2.071, 2.286, 2.5], 
p/r = [O, 0.114, 0.229, 0.343, 0.457, 0.571, 0.686, 0.8], 
c = [2.2, 2.357, 2.514, 2.671, 2.829, 2.986, 3.143, 3.3]. 
A set of corresponding 10 high frequency (with c divided by 1.35) catheter 
measurements were recorded (by running the numerical model with a primary mesh 
density of 0.2cm) for each of the 512 grid points using all combinations of the three 
model parameters: 
r (cm)= [1, 1.214, 1.429, 1.643, 1.857, 2.071, 2.286, 2.5], 
p/r = [O, 0.114, 0.229, 0.343, 0.457, 0.571, 0.686, 0.8], 
c = [l.630, 1.746, 1.862, 1.979, 2.095, 2.212, 2.328, 2.444]. 
The numerical modelling process was fully automated using ANSYS scripting. 
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Generation of test data was done by selecting 50 random parameter points. The 
probability of selecting a parameter point was uniform over the range: 
l.2cm < r < 2.3cm, 0.1 < p/r < 0.7, 2.4 < c < 3.2, and zero elsewhere. At each of 
these points a set of 20 catheter measurements were calculated. The first 10 
measurements were simply the 10 catheter measurements for the three different 
parameters at the point. The second set of catheter measurements were the 10 
catheter measurements calculated at the same r and p/r parameters as the point, but 
with a value of c equal to the c at the point divided by 1.35. The first 10 catheter 
measurements represented the response to lower frequency current and the second 10 
represented the response to higher frequency current at which the tissue conductivity 
was assumed to increase by 1.35. Along with the 20 catheter measurements the three 
parameters associated with them were stored. 
Inverse Mapping Using New Distance Function Technique 
Uniformly gridded base data was interpolated for any arbitrary three parameters r, p/r 
and c within the range of the base dat~ using MATLAB. 20 catheter measurements 
are generated using this interpolation process for any r, p/r and c. Optimisation was 
done to find the value of r, p/r and c, that gives the minimum mean squared error in 
the difference of the 20 interpolation generated catheter measurements and a 
particular set of 20 test data catheter measurements. The value of three parameters 
from the test data is then subtracted from the three parameter values given by the 
optimisation routine at its completion to give the error. The optimisation algorithm 
used was MATLAB's lsqnonlin('LargeScale','on') (non linear least squares 
optimisation) and the interpolation algorithm used was MATLAB's interpn('*linear') 
(linear interpolation). 
Base/training data was the same data used for the neural network inverse mapping, 
except the minimum value of c was reduced by 1.35. The use of interpolation 
allowed both low frequency and high frequency to be generated from just 10 catheter 
measurements (half the numerical model runs as done for neural networks). A set of 
10 catheter measurements were recorded (by running the numerical model with a 
primary mesh density of 0.2cm) for each of the 512 grid points representing all 
combinations of the three model parameters: 
r (cm)= [1, 1.214, 1.429, 1.643, 1.857, 2.071, 2.286, 2.5], 
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p/r= [O, 0.114, 0.229, 0.343, 0.457, 0.571, 0.686, 0.8], 
c = [1.6, 1.843, 2.086, 2.329, 2.571, 2.814, 3.057, 3.3]. 
The same test set of data was used that was generated for use with the neural 
networks as described in the previous section entitled Inverse Mapping Using Neural 
Networks. 
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5.3 Results 
Numerical Model 
A plot of the element mesh for a primary mesh density of 0.2cm is shown in Figure 
5.3.1. Note the mesh refinement around the electrodes that was used. 
Figure 5.3 .1: Finite element mesh for pnmary mesh density 
parameters: r = 1.75cm, p/r = 0.4, c = 1.75. 
0.2cm. Model 
Contour plots of the voltage potential solution for a primary mesh density of 0.2cm 
are shown in Figure 5.3.2 to Figure 5.3.5. The different figures show the effect of 
changing the source electrodes used. 
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Figure 5.3.2: Finite element solution (voltage) distribution. Source electrodes= 4 and 
7. Primary mesh density of 0.2cm. Numbers in legend are: voltage (V) x blood 
conductivity (S/m) I current (A) x width of model (m). Model parameters: r = 
l.75cm, p/r = 0.4, c = 1.75. 
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Figure 5.3.3: Finite element solution (voltage) distribution. Source electrodes= 3 and 
8. Primary mesh density of 0.2cm. Numbers in legend are: voltage (V) x blood 
conductivity (S/m) I current (A) x width of model (m). Model parameters: r = 
l.75cm, p/r = 0.4, c = 1.75. 
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Figure 5.3.4: Finite element solution (voltage) distribution. Source electrodes= 2 and 
9. Primary mesh density of 0.2cm. Numbers in legend are: voltage (V) x blood 
conductivity (S/m) I current (A) x width of model (m). Model parameters: r = 
1.75cm, p/r = 0.4, c = 1.75. 
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Figure 5.3.5: Finite element solution (voltage) distribution. Source electrodes = 1 and 
10. Primary mesh density of 0.2cm. Numbers in legend are: voltage (V) x blood 
conductivity (S/m) I current (A) x width of model (m). Model parameters: r = 
1.75cm, p/r = 0.4, c = 1.75. 
For various mesh densities the percentage difference of the 10 catheter measurements 
relative to the most finely meshed model is shown in Table 5.3.1. The convergence 
of therms error of all ten measurements is shown in Figure 5.3.6. 
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Table 5.3.1: Convergence of catheter measurements. Percentage difference of the 10 
catheter measurements relative to most finely meshed model. Model parameters: r = 
l.75cm, p/r = 0.4, c = 1.75. 
Mesh size 
(cm) 
Nodes 
Elements 
Variable 
Vi 
Vi 
V3 
V4 
Vs 
Vi 
Vi 
Vs 
Vi 
Vio 
0.0400 0.0433 0.0531 0.0694 0.0922 0.1216 0.1576 
125740 116889 81830 59468 40458 25311 19033 
41661 38728 27085 19675 13375 8352 6278 
Percentage change from 0.0400 mesh size 
0.0000 -0.0034 -0.0090 -0.0134 -0.0198 -0.0407 -0.0571 
0.0000 -0.0027 -0.0067 -0.0098 -0.0147 -0.0319 -0.0436 
0.0000 -0.0037 -0.0062 -0.0119 -0.0174 -0.0316 -0.0443 
0.0000 -0.0027 -0.0068 -0.0100 -0.0149 -0.0323 -0.0430 
0.0000 -0.0034 -0.0051 -0.0102 -0.0146 -0.0264 -0.0364 
0.0000 -0.0017 -0.0071 -0.0116 -0.0163 -0.0270 -0.0441 
0.0000 -0.0029 -0.0070 -0.0103 -0.0153 -0.0328 -0.0430 
0.0000 -0.0035 -0.0054 -0.0105 -0.0149 -0.0264 -0.0363 
0.0000 -0.0014 -0.0063 -0.0100 -0.0137 -0.0214 -0.0357 
0.0000 -0.0026 -0.0082 -0.0130 -0.0185 -0.0269 -0.0432 
x 10-4 
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Figure 5.3.6: Convergence of catheter measurements. Numbers plotted are: Absolute 
rms error of all 10 measurements (V) x blood conductivity (S/m) I current (A) x 
width of model (m). Model parameters: r = l.75cm, p/r = 0.4, c = 1.75. 
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Local Derivatives of the Numerical Model 
Local partial derivatives of the catheter measurements with respect to model 
parameters r, p/r, c are given in Table 5.3.2, 5.3.3 and 5.3.4 respectively. All the 
partial derivatives were calculated at the local point r = 1.75cm, p/r = 0.4, c =2.75 as 
described in Section 5.2. Each table gives the absolute derivatives calculated with a 
mesh density of 0.05cm, percentage derivatives (absolute derivative/absolute 
measurement voltage at the local point xlOO) and percentage difference between 
derivative calculated at 0.08cm mesh and 0.05cm mesh (to give an idea of accuracy). 
Table 5.3.5 shows the angles between absolute partial derivative vectors for different 
combinations of measurement variables. 
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Table 5.3.2: Partial derivatives with respect to r. units are: voltage (V) x blood 
conductivity (S/m) I current (A) x width of model (m) I change in r (cm), 100 I 
change in r (cm), 100 I change in r (cm). 
(absolute) (%) (~%) 
i av, av, 100 [ ( av, ) ( av, ) ) 100 -x-ar ar v, ar 008 - ar 005 xv, 
1 -0.0483 -17.6 -0.64 
2 -0.0631 -30.2 -0.33 
3 -0.0591 -25.5 -0.38 
4 -0.0700 -37.1 -0.30 
5 -0.0684 -35.1 -0.25 
6 -0.0622 -27.5 -0.18 
7 -0.0738 -40.9 -0.28 
8 -0.0730 -39.9 -0.23 
9 -0.0701 -36.5 -0.12 
10 -0.0627 -27.9 -0.38 
11 -0.0416 -15.4 -0.71 
12 -0.0554 -27.4 -0.34 
13 -0.0519 -23.0 -0.41 
14 -0.0623 -34.4 -0.32 
15 -0.0607 -32.4 -0.26 
16 -0.0550 -25.1 -0.19 
17 -0.0662 -38.3 -0.29 
18 -0.0653 -37.3 -0.23 
19 -0.0624 -33.8 -0.12 
20 -0.0555 -25.4 -0.41 
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Table 5.3.3: Partial derivatives with respect to p/r. units are: voltage (V) x blood 
conductivity (S/m) I current (A) x width of model (m) I change inp/r (cm/cm), 100 I 
change inp/r (cm/cm), 100 I change inp/r (cm/cm). 
(absolute) (%) (~%) 
i av. av. 100 
aP) --x- [ [ av, ) [ av, ) ) 100 aP) V. 
aP) oos - aP) oos xV. 
1 0.0612 22.3 1.05 
2 0.0590 28.2 0.81 
3 0.0519 22.4 -1.10 
4 0.0445 23.6 0.93 
5 0.0441 22.7 -1.22 
6 0.0410 18.1 -0.60 
7 0.0311 17.2 1.26 
8 0.0324 17.7 -1.59 
9 0.0377 19.6 -0.54 
10 0.0388 17.3 0.41 
11 0.0516 19.1 1.22 
12 0.0516 25.6 0.90 
13 0.0452 20.1 -1.22 
14 0.0408 22.5 0.98 
15 0.0398 21.3 -1.30 
16 0.0362 16.5 -0.66 
17 0.0298 17.3 1.26 
18 0.0306 17.5 -1.61 
19 0.0343 18.6 -0.56 
20 0.0343 15.7 0.45 
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Table 5.3.4: Partial derivatives with respect to c. units are: voltage (V) x blood 
conductivity (Sim) I current (A) x width of model (m) I change in c (Sim I Sim), 100 
I change in c (Sim I Sim), 100 I change in c (Sim I Sim). 
(absolute) (%) (~%) 
i av. av. 100 [ ( av. ) ( av. ) ) 100 -x-ac ac v. ac 008 - ac 005 xv, 
1 0.0060 2.2 0.02 
2 0.0078 3.7 0.02 
3 0.0072 3.1 0.02 
4 0.0084 4.4 0.02 
5 0.0082 4.2 0.02 
6 0.0073 3.2 0.02 
7 0.0085 4.7 0.01 
8 0.0085 4.6 0.01 
9 0.0082 4.3 0.02 
10 0.0073 3.3 0.01 
11 0.0072 2.7 0.02 
12 0.0094 4.7 0.02 
13 0.0087 3.9 0.02 
14 0.0102 5.6 0.01 
15 0.0099 5.3 0.02 
16 0.0089 4.0 0.02 
17 0.0104 6.0 0.01 
18 0.0103 5.9 0.01 
19 0.0100 5.4 0.01 
20 0.0089 4.1 0.01 
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Table 5.3.5: Angles (in degrees) between absolute partial derivative vectors. i = 1-10 
is low frequency data, i = 11-20 is equivalent high frequency data, i = 7-10 is 
segments between furthest separated source electrodes, i = 1,2,4, 7 is middle segment 
(for each of the four different source configurations). Refer to Table 5.2.1 in Section 
5.2 for precise definition of each i. 
i used dV/ dr to dV/ dp/r dV/ dr to dV/ de dV/ dp/r to dp/ de 
1-20 17.5 9.1 18.2 
1-10 18.1 1.4 16.8 
7-10,17-20 8.1 8.9 11.1 
1,2,4,7,11,12,14,17 21.1 9.2 21.2 
1,2,4,7 21.8 1.7 20.2 
~ 
Inverse Mapping Using Neural networks 
Table 5.3.6 shows the standard deviation (s.d.), mean, minimum and maximum of 
error in r parameter from inverse mapping using radial basis neural networks. The 
error is defined as the predicted r from the network minus the actual r of the test or 
training data. It should be divided by 1.75 (and multiplied by 100) to give percentage 
error. Two different networks are shown with different values of spread. Results for 
each network with test data and training data and are shown. Results from radial 
basis networks with different spread and multilayer neural networks with various 
configurations of hidden nodes were similar or worse than that in Table 5.3.6 and are 
not shown. 
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Table 5.3.6: Error in r parameter (cm). Radial basis neural network. Training data 
used 512 points based on 4096 numerical model simulations. 
Configuration s.d. error mean error mm. error max. error 
Spread= 0.04 
Test data input 
0.1095 0.0041 -0.3127 0.1810 
Spread= 0.04 
Training data input 
0.1422 -0.0071 -0.4523 0.2823 
Spread= 0.03 
Test data input 
0.1108 -0.0272 -0.3567 0.1438 
Spread= 0.03 
Training data input 
0.1202 -0.0071 -0.4052 0.2535 
Inverse Mapping Using New Distance Function Technique 
Table 5.3.7 shows the standard deviation (s.d.), mean, minimum and maximum of 
error in r, plr and c parameters from inverse mapping using the new distance 
function technique. The error is defined as the predicted parameter from the network 
minus the actual parameter of the test data. The error for r, p/r and c should be 
divided by 1.75, 0.4 and 2.75 respectively (and multiplied by 100) to give percentage 
error. Results are shown for test data identical to that used in Table 5.3.6. Results for 
base/training data set as input give essentially zero error with this technique and are 
not shown. 
Table 5.3.7: Error in r, p/r and c parameters (cm, cm/cm, S/m I Sim). New distance 
function technique. Training data used 512 points based on 2048 numerical model 
simulations. 
Parameter s.d. error mean error mm. error max. error 
r 0.0032 +0.0030 -0.0099 +0.0084 
p/r 0.0040 -0.0080 -0.0175 -0.0004 
c 0.0108 +0.0129 -0.0108 +0.0324 
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5.4 Discussion 
The results from the two dimensional model seem to have reasonable order of 
magnitude when compared to the results from the three-dimension models developed 
in Chapter 4. Comparing the numerical data in Figures 5.3.2 to 5.3.5 to Figures 4.3.1 
and 4.3.2, suggests a two dimensional model with width of about 3cm gives the same 
magnitude of results as a catheter in the left or right ventricles of the three 
dimensional model. It should be noted that the catheter used in this chapter is 
different from the catheter used in the last chapter. It has ten electrodes rather than 
eight and the electrode spacing is 8mm compared to 7mm. This does not affect 
comparison since results are contours in Figures 5.3.2 to 5.3.5 and not segment 
voltages. 
Derivatives with respect to r showed a strong decrease in catheter voltages with 
increasing r. Derivatives with respect to p/r showed a strong increase in catheter 
voltages with increasing p/r. Derivatives with respect to c also showed a relatively 
strong increase in catheter voltages with increasing c. While the magnitudes of 
derivatives with respect to c were smaller than the derivatives for r and p/r, c can 
vary by a much greater range. Looking at the percentage change in derivatives with 
increase in mesh density, all the derivatives change by less than 10% (comparing the 
last two columns of the tables), with derivatives with respect to p/r the least accurate. 
Derivatives with respect tor and c however showed a strong biased change in one 
direction with a change in mesh density. 
The angles between different subsets of the derivative vectors (Table 5.3.5) suggest 
frequency was very important for distinguishing c from r. Frequency (i = 11-20) 
played little part in separating p/r and c, and p/r and r. Different voltages from the 
same segment (i = 1,2,4, 7) were a significant factor in separating p/r and c, and p/r 
and r. In comparison the voltages from one particular source configuration (i = 7-
10,17-20) played a much less significant role. This supports the usefulness of 
different current source configurations for distinguishing p/r. Although not shown, 
angles between derivatives with respect to myocardium thickness showed thickness 
behaved almost exactly the same as c. It appears that from a distance away from the 
myocardium (as used in these calculations of derivatives) thickness cannot be 
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separated from c. The use of derivative angles gave a great insight into the inverse 
mapping. In addition, calculation of derivative angles is simple and does not require 
determining the inverse mapping. 
From Table 5.3.7 with worst case parameter error in the order of 1 % or less, it would 
appear the inverse mapping using all 20 catheter measurements to predict r, p/r and c 
exists and is relatively unique. When thickness was included in the predicted 
variables (not shown) the parameter error was very high suggesting a non unique 
mapping. This supports to some extent the angle data that suggests that c and 
thickness cannot be distinguished from each other. The method used to generate 
Table 5.3.7 was the new distance function technique. The neural network approach 
gave over 30 times the standard deviation of error and 30 times the worst case error 
as the new distance function technique. This suggests neural networks are incapable 
of solving this particular inverse problem. They are not well suited to ill-conditioned 
mappings, such as this one. 
The only limiting factor stopping the distance function from solving highly ill-
conditioned problems is numerical error introduced through approximation of the 
numerical model by interpolation. If optimisation was coupled directly to the 
numerical model (although impractical), it could theoretically produce an inverse 
mapping as accurate as the numerical error in the numerical model. It would then be 
possible to solve any highly ill-conditioned inverse problem that is unique. The 
problem then is not the ability to produce an inverse mapping. The largest problem is 
the effect of unmodelled error on the inverse mapping. If the catheter measurements 
cannot be found exactly in the numerical model (due to difference between model 
and experiment configuration or just electrical noise or offsets), the inverse method 
may not converge properly to the best parameters. In the next chapter the effect of 
such error on the inverse method is assessed. The distance function is also changed to 
make the inverse method converge to better parameters. 
The major limitation of the work in this chapter is that the results are based on a 2D 
model, not a 3D model. 
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5.5 Conclusion 
The work in this chapter suggests that it is possible to uniquely map catheter 
measurements alone to predict volume, catheter position and myocardium 
conductivity. The new distance function technique worked far better than neural 
networks in generating this mapping. The data presented shows that it is frequency 
that allows conductivity to be separated from volume. Also it shows that it is 
different current source configurations that allow catheter position to be determined 
from volume and conductivity uniquely. Thickness appears to be indistinguishable 
from conductivity (when the catheter is at distance from the myocardium anyway). 
The major limitation of the work in this chapter is that the results are based on a 2D 
model, not a 3D model. 
The next chapter will assess the performance of the distance function inverse 
mapping technique with unmodelled error. The technique will also be further 
developed. 
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Chapter 6. Investigation 3 
6.1 Introduction 
In this chapter the distance function technique used in Investigation 2 is extended to 
take account of unmodelled error. In Investigation 2 we showed that the distance 
function inverse approach may be used to obtain an arbitrarily close inverse mapping 
for small levels ofunmodelled error (arising from interpolation error). In this chapter 
the performance of the distance function technique will be assessed on data with a 
much higher level of error, similar to that expected in a real application. In addition, 
a more generalised technique will be developed based on the concept of finding the 
most probable model configuration for a given catheter measurement. This more 
generalised technique has the potential to improve inverse mapping with error 
corrupted measurement data and also has the potential to account for non-unique 
inverse mapping using probability information (in general, the distance function 
technique used in Investigation 2 will converge to an unknown non-unique model). 
In this chapter the more generalised technique will be applied to improve 
performance under the condition of unmodelled error magnitude that is not uniform 
for various variables or transformations of variables. Firstly in Section 6.2 it will be 
shown how maximising probability and minimising distance relate to each other. 
Unmodelled error in catheter measurements can come from a variety of sources. 
These include, with the approximate expected range of error in brackets: 
electronic noise (random gaussian distribution 0.1 %-10+%) 
electronic biased error (constant error 0.1 %-1 +%) 
catheter electrode spacing biased error (constant error 0.5%-10%) 
geometry differences between model and experiment (constant error 0.5%-10+%) 
other (random error up to 10% during free breathing respiration, posture) 
Factors complicate determining the most realistic amount of error for use in this 
chapter. For instance a more realistic three dimensional numerical model may be less 
sensitive to unmodelled error than the two dimensional model used for work in this 
chapter. 
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6.2 Theory 
In this section it will be shown how maximisation of probability is the same as 
minimisation of sum of squared error. 
The aim is to select the set of model parameters ( eg ventricle geometry, catheter 
position) that is most probable to produce a set of measurements ( eg catheter 
voltages). This problem can be stated as: 
Choose x1, x2, ... , Xm to 
maximise P = P(x1, x2, ... , Xm,y'i,y'2, .. . ,y'n), (6.2.1) 
where: P = probability density function, x1 = lh model variable, y 'i = lh measured 
variable (catheter or transformed catheter measurements). 
Now assuming the effect of each of the measurement variables is an independent 
Gaussian distribution of the error between measured variables and associated 
measurement variables from the model, P can be written as: 
(6.2.2) 
where: Yi = lh measurement variable from the model, Oi. = standard deviation of error 
between the ith measured variable and the ith measurement variable from model. 
Rearranging (6.2.2) gives: 
In P,(x1 ,x,. ,xm)Il r;;- -I-,-( " I ) " (y',-y,)' p = e 1=Icr1'1,J2.n i=l 2U1 (6.2.3) 
Maximising a monotonic function of P is equivalent to maximising P. Since the 
natural logarithm is a monotonic function, (6.2.1) can be written as: 
Choose x1, x2, ... , Xm to 
• • ( ) ( ( ) n 1 J n (y', -y, )2 max1m1se In p =In PX X1 'Xz ,. •. , xm IT r;:;- - L 2 
•=I a, v 2,. z=I 2a, 
(6.2.4) 
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Alternatively (6.2.4) can be written as, 
Choose x1, x2, ... , Xm to 
(6.2.5) 
Alternatively (6.2.5) can be written as, 
Choose x1, x2, ... , Xm to 
ml·m·m1·se -In(P)= ~ (y' 1 -y; )2 In(P ( )) In[rr" 1 ] .t.... x XpX2, ... ,Xm - r;;- . 
1=1 20-1 1=1 0-1 v 2tr 
(6.2.6) 
Since, 
n 1 
IT r;;- = C1, 
1=1 a v2tr 
I 
(6.2.7) 
where C1 is some constant, 
Equation (6.2.6) reduces to, 
Choose x1, x2, ... , Xm to 
(6.2.8) 
Alternatively (6.2.8) can be written, 
Choose xi, x2, ... , Xm to 
(6.2.9) 
where: A = constant selected to make the bracketed term always greater than zero. 
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Alternatively (6.2.9) can be written, 
Choose xi, x2, ... , Xm to 
(6.2.10) 
where: C2 = any constant. 
Equation (6.2.10) states that the most probable set of model parameters is one that 
minimises the weighted mean squared error including an extra error-like term that 
depends on the model variables. 
Now if, 
P(x1, X2, •• • , Xm) = C3, 
where C3 is some constant, 
then (6.2.10) can be reduced to, 
Choose x1, x2, .. . , Xm to 
minimise f. (S.- (y' 1 -y.)Y 
1=1 a 1 ') 
(6.2.11) 
(6.2.12) 
Equation (6.2.12) states that the most probable set of model parameters is the one 
that minimises the weighted (by some number inversely proportional to the standard 
deviation) mean squared error of measurement. 
If the error of measurement is identically distributed (6.2.12) reduces to, 
Choose x1, x2, ... , Xm to 
minimise f (y' 1 -y.)2. (6.2.13) 
1=! 
Equation (6.2.13) states that the most probable set of model parameters is the one 
that minimises the mean squared error of measurement. 
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Equation (6.2.13) was used in Investigation 2 and will be used again in the first part 
of the methods of this chapter. We have shown how this equation assumes uniform 
probability distributions of error for all variables. Equation (6.2.12) will be used in 
the second and third parts of the methods of this chapter. It allows for non-uniform 
probability distributions of error in variables. Equation (6.2.10) (which is in a form 
suitable for use with specialised least squares optimisation routines) and (6.2.8) will 
be discussed later in the chapter. These equations additionally allow incorporation of 
parameter variation probability. 
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6.3 Methods 
Numerical modelling in this chapter was identical to the last chapter and will not be 
repeated here. The exact same base/training data generation and interpolation of 
catheter measurements was done in this chapter as in the last chapter for the distance 
function based inverse mapping. The exact same MATLAB optimisation routine 
used in the last chapter, lsqnonlinO was used for methods in this chapter. The 
difference in this chapter is that error is applied to test measurements and a different 
distance function is optimised. The new methods and applications only will be 
presented. The methods are divided into three sections: Performance with Uniformly 
Distributed Unmodelled Error, Average/Difference Transformation to Reduce Biased 
Unmodelled Error, and Same Segment Ratio Transformation to Reduce Biased 
Unmodelled Error. The first methods section will provide information about how 
sensitive the inverse mapping is to uniform distribution of error added to 
measurement data. This information will be in the form of model parameter error. 
The second and third sections will introduce methods to minimise the effects of 
biased measurement error. These two sections seek to reduce the effect of biased 
measurement error by using transformations of measurement data that cancel it out to 
some extent. The optimisation bounds on the parameters were: l.2<r<2.3, 
O.l<p/r<0.7, and 2.4<c<3.2. The optimisation initial starting values were: r = 1.4, p/r 
= 0.6, and c = 3. 
Performance with Uniformly Distributed Unmodelled Error 
Generation of test data was accomplished by running the numerical model with the 
parameters r = l.75cm, p/r = 0.4 and c = 2.75 to generate 20 catheter measurements. 
50 sets of test data were generated by adding to this set of 20 catheter measurements 
random normally distributed error with mean of zero and desired standard deviation, 
s. 
The optimisation procedure was then used to minimise the mean squared difference 
between a set of all 20 (both frequencies) or first 10 (low :frequency only) test 
measurements and the data interpolated from the base data. The optimisation 
procedure was used to find all or a subset (with one or more parameters fixed to the 
actual value: p/r = 0.4, c = 2.75) of the three model parameters. Parameter error for r, 
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p/r and c was the final parameter from optimisation minus l.75cm, 0.4 and 2.75 
respectively. 
This procedure was repeated a number of times as detailed in Section 6.4 for various 
values of s, various parameters fixed in the optimisation, and different inclusion of 
measurement data (both frequencies/low frequency only). 
Average/Difference Transformation to Reduce Biased Unmodelled Error 
Generation of test data was accomplished by running the numerical model with the 
parameters r = l.45cm, p/r = 0.4 and c = 2.75 to generate 20 catheter measurements. 
This was repeated with the parameters r = 2.05cm, p/r = 0.4 and c = 2.75 to generate 
another set of 20 measurements. The first set of measurements with r = 1.45cm 
represent end-systole measurements while the second set of measurements with r = 
2.05cm represent end-diastole measurements. From these 40 measurements, 20 
average and 20 difference values were calculated. 50 sets of test data were generated 
by adding to this set of 40 transformed catheter measurements, random normally 
distributed error with mean of zero and desired standard deviation, s. The 20 average 
values had error added with a higher standard deviation to represent biased error. The 
20 difference values had a much smaller standard deviation of error added to 
represent some cancellation of biased error. 
The optimisation procedure was then used to minimise the weighted mean squared 
difference between a set of all 40 test measurements and the equivalent transformed 
data interpolated from the base data. The weights used had the appropriate ratio 
based on standard deviation of error applied as specified in (6.2.12). The 
optimisation procedure was used to find the parameters rl (end-systole r), r2 (end-
diastole r) and p/r. c was fixed at the actual value of 2.75. Parameter error for rl, r2, 
p/r was the final parameter from optimisation minus 1.45cm, 2.05 and 0.4 
respectively. Parameter error for the average and difference in r was the value 
derived from the final optimisation parameter minus 1. 75cm and 0.6cm respectively. 
For comparison purposes, the optimisation procedure was repeated with 50 sets of 
data created from the original 40 catheter measurements with uniform error added 
with standard deviation equal to that added to the average transformed data. The 
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-optimisation procedure was also repeated with 50 sets of data created from the first 
20 or second 20 original measurements only with standard deviation equal to that 
added to the average transformed data. In this case the optimisation procedure was 
used to find the parameters r1 only or r2 only, respectively, and p/r. 
Same Segment Ratio Transformation to Reduce Biased Unmodelled Error 
Generation of test data was accomplished by running the numerical model with the 
parameters r = l .75cm, p/r = 0.4 and c = 2.75 to generate 20 catheter measurements. 
From these 20 measurements 20 additional transformed variables were calculated. 
These 20 additional variables were: V1N2, V1N4, V1N1, V2N4, V2N1, V4N7, 
V3Ns, V3Ns, VsNs, V~9, V11N12, V11N14, V11N11, V12N14, V12N11, V14N11, 
V13N1s, V13N1s, V1sN1s, V14N19. These ratios contain measurements from the same 
segment at the same frequency, but with different current source electrode 
configuration. 50 sets of test data were generated by adding to this set of 40 catheter 
measurements random normally distributed error with mean of zero and desired 
standard deviation, s. The 20 original values had error added with a higher standard 
deviation to represent biased error. The 20 transformed values had a much smaller 
standard deviation of error added to represent some cancellation of biased error. 
The optimisation procedure then was used to minimise the weighted mean squared 
difference between a set of all 40 or just the 20 low frequency test measurements and 
the equivalent data interpolated from the base data. The weights used had the 
appropriate ratio based on standard deviation of error applied as specified in (6.2.12). 
The optimisation procedure was used to find the parameter r. p/r and c were fixed. 
Parameter error for r was the final parameter from optimisation minus l.75cm. 
This procedure was repeated a number of times as detailed in the Section 6.4 for 
various values of standard deviation and different inclusion of measurement data 
(both frequencies/low frequency only). 
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6.4 Results 
Results for this chapter are given in Tables 6.4.1 to 6.4.20. These tables summarise 
parameter error for each study. Standard deviation (s.d.) of error, mean error, 
minimum error and maximum error are tabulated for each parameter predicted by the 
inverse method in the study. Parameter error is the parameter predicted by the 
inverse method minus the actual test data parameter value. The parameter error is 
given in absolute form so different parameters with the same amount of error are 
actually a different percentage of error. Error data should be divided by 1.75, 0.4, 
2.75 (and multiplied by 100) to generate percentage parameter error for r, p/r and c 
respectively. Also presented in the tables is standard deviation of parameters divided 
by half the range of parameters (difference between maximum and minimum 
optimisation bounds) in percent. 
Performance with Uniformly Distributed Unmodelled Error 
Tables 6.4.1 and 6.4.2 show parameter error from studies with 0.25% standard 
deviation normally distributed error added to measurement data. Table 6.4.3 shows 
parameter error from a study with 0.5% standard deviation normally distributed error 
added to measurement data. Tables 6.4.4 to 6.4.8 show parameter error from studies 
with 1 % standard deviation normally distributed error added to measurement data. 
Tables 6.4.9 to 6.4.12 show parameter error for studies with 4% standard deviation 
normally distributed error added to measurement data. Table 6.4.13 shows parameter 
error for a study with 8% standard deviation normally distributed error added to 
measurement data. Different studies show different combinations of parameters 
fixed/predicted and different amounts of measurement data used (both 
frequencies/low frequency only). 
Table 6.4.1: Parameter error. Data from both frequencies used. Added error standard 
deviation = 0.25%. Parameters used for test data: r = 1.75, p/r = 0.4, c = 2.75. 
Parameters fixed: none. Parameters solved for: r, p/r, c. 
Parameter s.d. mean error min. error max. error %s.d./range 
r 0.0121 0.0080 -0.0160 0.0420 2.2 
p/r 0.0122 -0.0073 -0.0298 0.0152 4.1 
c 0.0728 0.0415 -0.0930 0.1727 18.2 
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Table 6.4.2: Parameter error. Low frequency data only. Added error standard 
deviation = 0.25%. Parameters used for test data: r = 1.75, p/r = 0.4, c = 2.75. 
Parameters fixed: none. Parameters solved for: r, p/r, c. 
Parameter s.d. mean error min. error max. error %s.d./range 
r 0.0360 0.0093 -0.0548 0.0775 6.5 
p/r 0.0173 -0.0058 -0.0414 0.0434 5.8 
c 0.3367 0.0911 -0.3500 0.4500 84.2 
Table 6.4.3: Parameter error. Data from both frequencies used. Added error standard 
deviation = 0.5%. Parameters used for test data: r = 1.75, p/r = 0.4, c = 2.75. 
Parameters fixed: none. Parameters solved for: r, p/r, c. 
Parameter s.d. mean error min. error max. error %s.d./range 
r 0.0259 0.0099 -0.0428 0.0709 4.7 
p/r 0.0191 -0.0039 -0.0454 0.0468 6.4 
c 0.1754 0.0519 -0.3401 0.4500 43.85 
Table 6.4.4: Parameter error. Data from both frequencies used. Added error standard 
deviation = 1 %. Parameters used for test data: r = 1.75, p/r = 0.4, c = 2.75. 
Parameters fixed: none. Parameters solved for: r, p/r, c. 
Parameter s.d. mean error mm. error max. error %s.d./range 
r 0.0403 0.0159 -0.0650 0.1028 7.3 
p/r 0.0403 -0.0007 -0.1140 0.0810 13.4 
c 0.2831 0.0812 -0.3500 0.4500 70.8 
Table 6.4.5: Parameter error. Data from both frequencies used. Added error standard 
deviation = 1 %. Parameters used for test data: r = 1.75, p/r = 0.4, c = 2.75. 
Parameters fixed: c. Parameters solved for: r, p/r. 
Parameter s.d. mean error min. error max. error %s.d./range 
r 0.0312 0.0061 -0.0680 0.0768 5.7 
p/r 0.0505 -0.0037 -0.1877 0.0947 16.8 
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Table 6.4.6: Parameter error. Low frequency data only. Added error standard 
deviation = 1 %. Parameters used for test data: r = 1.75, p/r = 0.4, c = 2 .75. 
Parameters fixed: c. Parameters solved for: r, p/r. 
Parameter s.d. mean error mm. error max. error %s.d./range 
r 0.0337 0.0037 -0.0578 0.0668 6.1 
p/r 0.0562 -0.0063 -0.1288 0.0997 18.7 
Table 6.4.7: Parameter error. Data from both frequencies used. Added error standard 
deviation = 1 %. Parameters used for test data: r = 1.75, p/r = 0.4, c = 2.75. 
Parameters fixed: p/r. Parameters solved for: r, c. 
Parameter s.d. mean error mm. error max. error %s.d./range 
r 0.0394 0.0070 -0.0676 0.0631 7.2 
c 0.2827 0.0407 -0.3500 0.4500 70.7 
Table 6.4.8: Parameter error. Data from both frequencies used. Added error standard 
deviation = 1 %. Parameters used for test data: r = 1.75, p/r = 0.4, c = 2.75. 
Parameters fixed: p/r, c. Parameters solved for: r. 
Parameter s.d. mean error mm. error max. error %s.d./range 
r 0.0075 0.0073 -0.0107 0.0250 1.4 
Table 6.4.9: Parameter error. Data from both frequencies used. Added error standard 
deviation = 4%. Parameters used for test data: r = 1.75, p/r = 0.4, c = 2.75. 
Parameters fixed: none. Parameters solved for: r, p/r, c. 
Parameter s.d. mean error mm. error max. error %s.d./range 
r 0.1061 0.0133 -0.1920 0.2452 19.3 
p/r 0.1713 -0.0322 -0.3000 0.2335 57.1 
c 0.3744 0.1016 -0.3500 0.4500 93.6 
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-Table 6.4.10: Parameter error. Data from both frequencies used. Added error 
standard deviation= 4%. Parameters used for test data: r = 1.75, p/r = 0.4, c = 2.75. 
Parameters fixed: c. Parameters solved for: r, p/r. 
Parameter s.d. mean error min. error max. error %s.d./range 
r 0.1070 0.0327 -0.1203 0.2598 19.5 
p/r 0.1804 -0.0114 -0.3000 0.2487 60.1 
Table 6.4.11: Parameter error. Low frequency data only. "Added error standard 
deviation = 4%. Parameters used for test data: r = 1.75, p/r = 0.4, c = 2.75. 
Parameters fixed: c. Parameters solved for: r, p/r. 
Parameter s.d. mean error min. error max. error %s.d./range 
r 0.1817 0.0483 -0.1407 0.5500 33.0 
p/r 0.2068 -0.0215 -0.3000 0.3000 68.9 
Table 6.4.12: Parameter error. Data from both frequencies used. Added error 
standard deviation= 4%. Parameters used for test data: r = 1.75, p/r = 0.4, c = 2.75. 
Parameters fixed: p/r, c. Parameters solved for: r. 
Parameter s.d. mean error mm. error max. error %s.d./range 
r 0.0367 -0.0025 -0.0742 0.0780 6.7 
Table 6.4.13: Parameter error. Data from both frequencies used. Added error 
standard deviation= 8%. Parameters used for test data: r = 1.75, p/r = 0.4, c = 2.75. 
Parameters fixed: p/r, c. Parameters solved for: r. 
Parameter s.d. mean error mm. error max. error %s.d./range 
r 0.0921 0.0020 -0.1720 0.2176 16.7 
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Average/Difference Transformation to Reduce Biased Unmodelled Error 
Tables 6.4.14 to 6.4.17 show the effect of average/difference transformation (as 
discussed in Section 6.3) on prediction error. Table 6.4.14 is from a study using the 
transformations, whereas Table 6.4.15 to 6.4.17 are from equivalent studies not using 
the transformations but with similar measurement error magnitude added. 
Table 6.4.14: Parameter error using average/difference transformation. Data from 
both frequencies used. Average error standard deviation= 4%xVaverage and difference 
error standard deviation= 1 %xVaverage· Parameters used for test data: rl = 1.45, r2 = 
2.05, p/r = 0.4, c = 2.75. Parameters fixed: c = 2.75. Parameters solved for 
simultaneously: rl, r2, p/r. 
Parameter s.d. mean error mm. error max. error %s.d./range 
rl 0.0313 0.0012 -0.0733 0.0688 5.7 
r2 0.0600 -0.0213 -0.1760 0.1049 10.9 
Diff. r 0.0290 -0.0225 -0.1028 0.0360 5.3 
Av.r 0.0456 -0.0100 -0.1246 0.0869 8.3 
p/r 0.0536 -0.0267 -0.2014 0.0745 17.9 
Table 6.4.15: Parameter error using no transformation. Data from both frequencies 
used. Error standard deviation= 4%xVaverage· Parameters used for test data: rl = 1.45, 
r2 = 2.05, p/r = 0.4, c =2.75. Parameters fixed: c = 2.75. Parameters solved for 
simultaneously: rl, r2, p/r. 
Parameter s.d. mean error mm. error max. error %s.d./range 
rl 0.0716 -0.0039 -0.1137 0.1487 13.0 
r2 0.1454 -0.0124 -0.2380 0.2500 26.4 
Diff. r 0.0744 -0.0085 -0.1243 0.1297 13.5 
Av.r 0.1084 -0.0081 -0.1758 0.1993 19.7 
p/r 0.1703 -0.0634 -0.3000 0.2025 56.8 
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Table 6.4.16: Parameter error using no transformation. Data from both frequencies 
used. Error standard deviation= 4%xVaverage· Parameters used for test data: rl = 1.45, 
p/r = 0.4, c = 2.75. Parameters fixed: c = 2.75. Parameters solved for: rl, p/r. 
Parameter s.d. mean error min. error max. error %s.d./range 
rl 0.0575 0.0109 -0.1083 0.1194 10.5 
p/r 0.1630 -0.0312 -0.3000 0.2194 54.3 
Table 6.4.17: Parameter error using no transformation. Data from both frequencies 
used. Error standard deviation= 4%xVaverage· Parameters used for test data: r2 = 2.05, 
p/r = 0.4, c =2.75. Parameters fixed: c = 2.75. Parameters solved for: r2, p/r. 
Parameter s.d. mean error min. error max. error %s.d./range 
r2 0.1589 0.0104 -0.2430 0.2500 28.9 
p/r 0.1838 -0.0428 -0.3000 0.2193 61.3 
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Same Segment Ratio Transformation to Reduce Biased Unmodelled Error 
Table 6.4.18 to 6.4.20 are all from studies using same-segment ratio transformations 
(as discussed in Section 6.3). Table 6.4.18 is from a study using data from both 
frequencies and lower added measurement error. A comparison study not using the 
transformations would be the study in Table 6.4.12. Table 6.4.19 is from an 
equivalent study with twice as much error. A comparison study not using the 
transformations would be the study in Table 6.4.13. Finally Table 6.4.20 is from a 
study equivalent to Table 6.4.19 but with only low :frequency data used. 
Table 6.4.18: Parameter error using same-segment ratio transformation. Data from 
both frequencies used. Error standard deviation = 4% and same-segment ratio error = 
1%xVratio· Parameters used for test data: r = 1.75, p/r = 0.4, c = 2.75. Parameters 
fixed: p/r = 0.4, c = 2.75. Parameters solved for: r. 
Parameter s.d. mean error min. error max. error %s.d./range 
r 0.0102 0.0044 -0.0120 0.0241 1.9 
Table 6.4.19: Parameter error using same-segment ratio transformation. Data from 
both frequencies used. Error standard deviation = 8% and same-segment ratio error = 
2%xVratio· Parameters used for test data: r = 1.75, p/r = 0.4, c = 2.75. Parameters 
fixed: p/r = 0.4, c = 2.75. Parameters solved for: r. 
Parameter s.d. mean error mm. error max. error %s.d./range 
r 0.0270 -0.0013 -0.0588 0.0660 4.9 
Table 6.4.20: Parameter error using same-segment ratio transformation. Low 
:frequency data only. Error standard deviation= 8% and same-segment ratio error= 
2%xVratw· Parameters used for test data: r = 1.75, p/r = 0.4, c = 2.75. Parameters 
fixed: p/r = 0.4, c = 2.75. Parameters splved for: r. 
Parameter s.d. mean error mm. error max. error %s.d./range 
r 0.0413 0.0031 -0.1090 0.1184 7.5 
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6.5 Discussion 
The mean error presented in the results gives the sort of error that can be expected in 
the average parameter values predicted when random noise with mean of zero is 
present in the catheter measurements. The standard deviation is a more appropriate 
indicator of the effect of biased error, or a single unaveraged parameter prediction. 
Values of %s.d./range close to 100 indicate no predicting ability in the case of biased 
error. In general, the mean parameter error is quite low throughout the results, 
suggesting that random noise with mean of zero can be reduced through averaging 
the parameter predictions (however, filtering the measurement data would probably 
give better performance). 
As indicated in the first part of the results, it would seem that the inverse mapping is 
very sensitive to unmodelled error. Even with only 1 % measurement data error the 
parameter error standard deviation is 10 times that in the last chapter (Table 5.3.7) 
and on the order of several percent for both r and p/r. However with just this 1 % 
error c is almost unpredictable (Table 6.4.4). With 0.25% error c is also 
unpredictable from just low frequency data (Table 6.4.2). The data supports the 
conclusion in the last chapter that frequency is primarily responsible for separating c 
from r. With 1 % error, fixing c or p/r only, has marginal effect on improving the 
accuracy of the other parameters. Accuracy is only significantly improved when both 
p/r and c are fixed. It would appear that c and p/r can not be predicted from a 
distance away from the myocardium (as modelled in this chapter) when this level of 
error is present. Filtering could probably be employed to reduce random error 
through filtering of measurement data and/or extensions to the method as discussed 
later, however it would not reduce biased error since it does not have a mean of zero. 
Average/difference transformation appears to be useful in improving the accuracy of 
the difference in r, equivalent to stroke volume. Parameter error was reduced two to 
three times using the technique between table 6.4.15 and 6.4.14. Additional studies 
used for comparison purposes, Tables 6.4.16 and 6.4.17, show a marked decrease in 
accuracy of predicting parameters when r is larger. This would suggest the length-of-
catheter to r ratio should be made as large as possible to improve accuracy. 
Alternatively, placing the catheter closer to the myocardium may help. These two 
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tables when compared to Table 6.4.15 also suggest there is no significant difference 
between inverse mapping two single measurements separately or simultaneously 
coupled in the p/r variable. The p/r value given is similar to an average of that given 
by the independent inverse mappings. It should be noted that the average/difference 
transformation only works because the biased error is the same at the two different r 
values, allowing some sort of cancellation. 
Same segment ratio transformation also appears to be very useful. Error in Tables 
6.4.18 and 6.4.19 were reduced by a factor of about three times over Tables 6.4.12 
and 6.4.13. It should be noted that this transformation relies on having different 
source electrode configurations. Otherwise, the only way of getting a different 
measurement across the same segment is to change the frequency. The 
transformation may cancel out biased error such as catheter manufacturing error or 
local field effects on electrodes such as trabeculations. 
The extension of the distance function technique to incorporate a priori assumptions 
about relative error magnitude of catheter measurements, appeared to be useful, 
based on its applications with the two transformations. 
A further extension of the distance function technique to incorporate a pnon 
information about the probability of different parameters occurring, maybe useful for 
filtering out random error from measurement data and allow the technique to solve 
non-unique mappings by making them unique with added probability information. 
Applying filtering may also speed up the optimisation. 
Limitations of the work in this chapter are, that like the last chapter, results were 
from a two-dimensional model rather than a realistic three-dimensional model. Other 
limitations are that the extended distance function technique assumed a normal 
distribution of error. This is probably a reasonable assumption based on the ideas of 
the central limit theorem. However in practise a different distribution could probably 
be zeplaced with a normal distribution with the same standard deviation (second 
moment of inertia) with little error. Using the normally distributed error assumption 
allows optimisation of the natural logarithm of the probability using specialised, 
more efficient optimisation routines. When inverse mapping data in this chapter, the 
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ratio of error standard deviations was set to the known ratios of added error, in a real 
application it may be different. Something that was not addressed in this chapter was 
that of non-independent error. This is especially important when adding 
transformations of variables to the distance function. The weighting of non-
independent variables should be reduced/shared. 
In all the studies in this chapter parameters optimised were in the form of the 
variables r, p/r, c. Transforming these variables (or carefully selecting parameters) 
into new variables may make the optimisation search space smoother. Optimisation 
algorithms work best with particular function shapes. However one may have to 
recalculate the base data based on an even grid of the new variables to enable easy 
setting of optimisation bounds. Changing the optimisation to optimise the probability 
directly would be impractical due to the large range of values. The distance function 
essentially is the natural logarithm of the probability, greatly compressing this large 
range of values. 
When a variable was fixed during optimisation it was set at a known value. In 
practise one may not know tpe fixed parameters exactly and fixing them to an 
incorrect value may give some error. An implicit assumption throughout this chapter 
and the last was that :frequency caused a known change in conductivity. The effect of 
this :frequency change not being known exactly, may give some error. 
6.6 Conclusion 
The work in this chapter suggests it is not possible to determine catheter position or 
myocardium conductivity very accurately when placed a large distance from the 
myocardium when moderate error is present. The inverse mapping is highly sensitive 
to unmodelled error. A catheter may have to be placed close to the myocardium to 
get some idea of catheter position or myocardium conductivity under experimental 
conditions. A longer length catheter may have the effect of achieving the same result. 
The extended distance function technique developed in this chapter allowed 
parameter error to be reduced. Similar to Chapter 5, the major limitation of the work 
in this chapter is that the results are based on a 2D model, not a 3D model. 
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-Chapter 7. Conclusion 
Summary 
The conductance catheter is the one of the most promising techniques for use as an 
implantable blood flow sensor. While the low power consumption of the technique is 
one of its main advantages, the existing accuracy of the technique is insufficient for 
the intended application. Improvement in accuracy may be possible if more of the 
data available from the conductance catheter is utilised. The problem then is the 
complex task of mapping available data to changes in ventricle geometry. 
Through development of numerical models the accuracy of the conductance catheter 
was assessed. The models provided a controlled experimental environment. 
Catheter movement was found to be highly significant as well as blood 
conductivity/myocardium conductivity ratio. 
A method for mapping a large number of conductance catheter measurements to 
ventricle geometry was developed. This involved finding the inverse solution to a 
numerical model. Two approaches were employed, a new technique and neural 
networks. These approaches were tested on a two-dimensional simplified heart 
model. The new technique was shown to be capable of close to exact inverse 
mapping, while a wide array of neural network techniques failed comprehensively. 
Numerical model derivative information was used to gather an insight into the 
inverse mapping. Derivative angles between different numerical model parameters 
were calculated to determine the relative effect and separability of different model 
parameters. 
The new inverse technique was applied to data with error. The effect of error and 
how it related to angles between the derivative vectors of various variables was 
examined. The technique was further developed and applied to reducing biased 
experimental error, due to catheter geometry difference between model and 
experiment and other unmodelled error. The improved technique significantly 
reduced error from these sources. The improved technique also has the potential to 
be used in a temporal filter of random unbiased error in the data. 
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-The inverse technique developed is relatively computationally intensive and requires 
a parameterized numerical model to be developed to use it, however it offers the 
possibility of determining blood flow accurately from a conductance catheter. The 
parameterised numerical model provides a convenient way of incorporating a priori 
geometry and conductivity information and the improved new inverse technique 
provides a convenient way of incorporating a priori error and parameter dynamics 
information. 
Future Work 
Many opportunities are available for future work in relation to this topic. 
The work of investigation one (chapter four) is limited to one particular catheter 
geometry. The catheter used was relatively short. A longer catheter may give 
different results. Modelling a different catheter geometry may require extending the 
models into the atria and pulmonary artery/aorta. It was assumed no current flowed 
outside the heart myocardium. In reality some current will flow through the liver and 
epicardial fat (if it is thin or non-existent) into surrounding structures. Fibre 
direction, even though the resulting conductivity can probably be safely assumed to 
be equivalent to some isotropic value, could be incorporated into the models. 
Trabeculation, even though the resulting model can probably be safely assumed to be 
a smooth border between blood and myocardium, could be incorporated into the 
model. Rough experimental validation of aim three could be achieved by wiggling an 
equivalent conductance catheter around inside a patient and by changing the 
blood/myocardium conductivity ratio using saline injection. 
The inverse mapping technique could be further developed in a number of ways. The 
work done in the second and third investigation chapters could be applied to three-
dimensional models like those used in investigation one rather than a simplified two-
dimensional model. It is desirable to perform experimental validation, but even if 
blood flow can be measured independently, a major problem is gathering the 
required geometry and conductivity information to compare with that predicted by 
the model. 
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The inverse mapping method provides the potential to determine tissue conductivity 
and its variability more accurately than experimental techniques, due to no damage to 
the tissue, in a wide array of living animal or even human subjects. For instance a 
catheter with closely spaced electrodes could be placed in the blood pool next to the 
heart wall in desired location, and assumed fibre direction and geometry could be 
used to generate numerical model data for the inverse solution of tissue conductivity. 
Other types of sensor could be developed to overcome regurgitation error problems 
with the conductance catheter technique. Ultrasound could be explored, as a future 
improvement in battery technology (fuel cells?) could make such techniques more 
feasible for implantable use. Studies could investigate how well a single crystal 
catheter could measure flow in a pulmonary artery of a pulmonary hypertensive 
patient with heterogeneous velocity profile. Also viscous pressure drop measurement 
of velocity using some sort of conductance catheter type correction for blood 
viscosity (from hematocrit) and flow cross-sectional area could be explored. New 
concepts based on biotechnology/nanotechllology such as collecting/synthesizing and 
then releasing and measuring a marker in the blood to obtain blood flow using 
indicator dilution formulae could be another future option. 
This thesis has developed and tested new conductance catheter methods, and has 
moved us a step closer to enabling practical development of an implantable blood 
flow and pressure monitor. 
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